var title_f11_15_11504="Pancreatocele";
var content_f11_15_11504=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F60893&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F60893&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Endoscopic retrograde cholangiopancreatography (ERCP) showing pancreatocele",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 347px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFbAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDfUkHBJ5p8LMMgnOKrbtzBRkD1qeMYNAFpc46n8Ksx5OMA1WibJA7+laMURQ5NAFi3jxgt0q9BIVyQOKqLICMYzUwyD7UAXFkJHSjzW6cgVAGwg+tSqR6e9AEgOO1Rynuc0pcAjng1BLIG7496AIJnJBAyRVQEhhU8xwp461U3DnmgCfr944qSPr1OKrxnc30qzGCGGASfSgC5bAlv0zVwkYxnpUNum1RUgYY5oAcDgH1o3EAZ70Z9OaR/egAYnPHSk3HHFBPuaaxxQABj1pQx7mmAn6UjZxgUAP3fhVeSTJ60ksgAx19qhZu4GaAHhiSOpNWLddz1UHzEGtGxTALNnOeKALhI4xzxirlmpaMnP1qiAWfAPFaqARw4FAAoGSMYqQcColYsc9KlK9MnigBY2OfrU7EBcc1XhH7zkcCpXJJoAikywOaqvweDwKt/xVC68mgCnvJ61FltmHxuOTwamdDuIFV5DjpyPSgABI4PBpyOVOOeajXJ+uaN3HPXNAE7OTjrUkHzMMk5qsu7J6VbgAAyaAG3UmflGTVdmwOM066cCT3qq0mPrQBLISyY5+prE1KNSOnJ4zWjPMScKOR3qncZeIk0Adb4Vffo0K/3PlrWJ+Uiub8Fz7reeL+62RmukI6+9AFFbpZFkCFjtODxVZJ3kikBQrtPGe9aJUDPA9elVnKbmGR9BQB8a/tBWU1l8QLiSRQpuEEg29CBxXme488n8691/aptgNZ0q5QjmNlb1GOleEnlaAAO3qaRnbHU0h6U0mgBd7HufzpAzbxyetJQPvj60AfWCtucADABq6oyRjpVEMQcCrsCn7xJoAtW64JYnPPFaMbZ/kTVKMZxVyDg8UAWYwOw4qYZGOeaiXkEkcelSr8o+bkGgCUsMfSmvJkHBxUTthetR789KAJhITzkcUxjg4zUYYgnApuW6GgBJ+h56VSLHpU8z8HPWs92+YkEigC7CTnmta2j3AMTisW2PPrW7bE7BQBYxinH5frTevajOSe1ADuR3oJBximluaTd70AO/nTWPNG7mhsUAJSN93mnDGKjf60AQkAkHPWo2UYDCpiM9hUix7sE0ARW0Jds/wANaiLhMY4pkcW0YHSrAUYx2oAdaR7nLHoKnlkwPlbvURfy4wkfHr70i9RgUAXLd8sNw5q4Y92CKzos55q9HLtAoAkCbQc96a2MDmgTbuvFMY54BFAATgZqNj7Yoc4UCkdyKAIWQnOD1qBoT1x3q1nPNLwOMUAUTAynIGRTWgJ6Ka0k9MVOgAXoCaAMgRFOvep4htU7hV+aNWjyV5FVHGSR7UAULsgPuI/CqMjgHGM1oX2CnP3qzZMhcjk+tAEG5gpL9T+lJvDZBPFMnfPYg96gLhehH50Ab/hGTGpSx84ZM115zkDNcH4akK6zFggBgR1ruyfWgCvNG/mFt3GOlZr2YW887c2cbcZ4/KtaYgDiqF3I4IKoMetAHgv7Uemp/YNjfBR5kc+xm9iK+ZX9BX1p+0ehuPANwvlMwR1feP4ea+Sz0OaAGUlLSUAFA++PrRQPvj60AfWMEeZCzetaMPJxTI4uA2KswqB+NAFhAMdqnQHAqJFGO1SqwxjuKAJ1zmnb8Dmq7SnOOmKjaTJOTQBMZDnNC4ZuPvVCHOOlPTI60ATg5GO9Mlb0PSnDkHPXtVSRiCwoAbK341W25bIqYgnjmlRcHvQBPZRd+DxWtEMKO1VrOLCAnpVrGc57UASg89aXdziowenWlzzQBJnIpOwzTc0vBFABQelAINI3QYoAFI4xmmt0p4HrxQEy1ACRRgnOKtogVRxQiADPpUgzjIFACxjjmnKePaoZZQi8HnFOtZVPD4BPegCdUOcjr71Mq4HvSjbkGpQwGBxQBEuQOKkBOOaeApHJ60vlgYOQaAIiec5pyuc9aXyuc459ajZDg5oAtj519KhkT1JNLASBTnJwc9aAIxjkVFzuxnpTzntSEAigB6kgmpI39aixlcd6fGOenFAFkH5KqFQGPJq1n5MioZMYoAzL+PJHU5qlMyRZ3ntxU2r3RiiYr6YFcldXcsjBmYnnoaANSeRXYncPaqbbd3T8apx3IIw/epnO4ZXGPUUAX9JkEOpW8jHneAMV6XwQM968fhlI1CHOTtcH9a9eQ7olI7gGgBWAxyKpXGwDB61bOdtUZxmT7vIoA4P4xWy3fw/1lAobEJbH05r4kI4H0r7q+IGntd+GdRjDsn7h84P3uK+GJRtZwRgqSMfiaAIz0ptOJ4ptABQPvr9aWkH3xQB9jxgMSM8VKFCY71WVwv8AjT/MY9T1oAtCQBMkU3fx6VXZsAZzkVG0hbAH50AWvN3ORTs5FVl6jnNToTigCZGOMVKhwaiQZapgMf1oAe4KoeKpM4zg9DVyVv3fU1R2nOSRQA8Lls84q1bQFiNwplsgZsf/AKq0EjDn5etADgoXFPXJ61Edw4ORinB84UcUAS80Zy2e1Jn3pcZ5GKAJOo4ppYBgPWk4B/xpG5OcCgBw4PWg4NIMkY/WpFTBAJ5oAEUHkg1YXA6CgLgdKcvv1oAcvHWiRgF4NI74XIqhLISSATQBKXz0pOAQc80xMnp1qURkjJGfpQAqTumcMcVKbx9uOKWOAYx0zSC3Ge5/CgAW54zg/nTxd8feIqJrbH3WpPs7bcgigC2l2/PzcGpFunx61SWCTIAOasRxOhUEH0oAvRT4AzUhmXuKos5UYKnikaTI6UAXgyE8HFKAD0OaoiTnv9KernGentQBc2HPJ5p8YwDVWK4OTzkVMkwx6ZoAsIvyGqVwxC1diYHIHPFUbrqQSOtAHPaq5bAPQVz8w+bk5x7V0GqKFfJFYFwc/wBaAKcpUnp0qMXDRAnHA96c33iarTYfI54oAuWcyyurA4bOa9isiTZwk90H8q8MhDLONpxXtuiv5mlWpBOfLGc0AWyRiqE24TnAPTNXiMfWqV0yrOgY8mgDC8TnbpN55gJVomHA9q+DNRj8m9uEHQSuB/30a/QHUUWSCRTjlSMV8FeKohD4h1RApXFy/H40AZPPeikFFABQP9YB70UAYkX60AfXKPnv3qdWyMZwaqq3U+9SGTCkg0ATO3OOaauc4HeoA+cH72P0qdOcGgCzGM46cVOoGKgj+lWFGMYFAEkfUY6Gpxg85pkSMy8cCp1gAAy2BmgCMj923FVMnJ44rUIjWNsn5j61X2/MMCgB1mhbjpVzlGXaeKW1iO0ZHNWBFgHPSgCtsLcnrTSCnXH41ZdQoycYFc5qt+zOUQ8CgDbSRDxuXP1qRCK4ozyB9wJ/OtC11lkwrDdnigDpT0pAOtVrW8juB8rfhV9APWgBUTpkVJsy/BxSfTpS5I5waAJcnIyaZJKF44pk0yoCSelUHkLt6etAE8srSHCnpUWOcn8ajzg+wpxOR1/CgC1aklzmtFFBwcisi3Yq4J6GtONsY5oAtouDycj0p4VOwxVdGY9MH1qQMe9AD9qmniJSccc+1NGfTirMKY5PWgBVgjXGAM+1OeBcrg0/PHUUj5+U0ARTW5PGQRVd7Uj0/CrkpwKgLnBOeBQBTMPPXB96YYnHI5x71aMuTim71zyKAIU3ZwRg1K6lVU5xVmAo5A4qSaFSAM4oArRMQCaqysWcjJq/NFsjG05/CqagjO4c0AYOrI7N1NYU+RkV1l7Dvl9jWFfWuN3HIoAwpjgkd6pSNtcVauAVPvWfdFi2OlAE6yL1Xk17H4XcvoFm3Q7BXgl1c+QvXn0r2vwFcG48KWMvJBUj9aAOiIOOTVS7QeYjbQSDwatlvkGB+dVZw7AbSBg0AU9QiMkbAfKSOtfC3xCga28ZaxG3zAXDDP48V923W5VyefWvib4tQ7PHesbAQDOWOfpQBwpGKSp3T5ahIxQAlH8a/WigffH1oA+rTJgHHrSx/N0NVA25sgcZq1FwcdqALCnjpVqDkVXj547VaiHtQBZjTI9KtoAMd6hj9TUm4Bc4JoAmMoRfemi4HPrVWQlhnH61FCWB+agDQVzJ1qzFjOM8VSiPfIxVyJwQKANa1AIUd6tFARzWfBIFIYkAVLJfIRtjIPrmgCrq0xCFE6d8Vx90jbjycmunumVgSOc1iXkG85Q8elAGHKzDg8URDvnJ9KuyQDksT+FVn/dqB1U9zQBZjuDEQyNhgOtalprLLgS8+9YAwXytSKwHXNAHaQalDIFw+0/SrJuo2jJDAf1rgxdCPOCTipor12I+ZgO3NAHUySFyd3Q9KQnkgj6VTs7gyRjceatZAPPWgCYYIwTgUEjBzSEjgkUYLcDGKAFUnjjvxWwn3Vz6VkFTkADNbCofLU+1AD1HOR1q3ChY4xzUKAkgYq9brg5z0FAEkYA6jmpmUAZHFQ7uc9qmLfuqAISfmwKcx+XHtUYwZKZevsi+vFAEck3HPU1EWyeOlQkkj+tLuAbrQAxyQ2ScUisABzzTSwdicHioXPzYz0oAvwyDOcitFmBCntXPq2wjrV1pmA4OeOmaANEShnAAxSTIp5A5rOt5WMgIPFXZJwEOOtAGdckB846Vm3Pzg9MGrk8oMrEdOlZ053EgAjFAGJd20bOcjpWTe2owe3FdFdISMgdK5vX5mjt2C9cUAcjrLHLYbAHQ17d8KWP/AAhNlv5+9j86+fdRumklI6qOK+gvhWA3gmx+h/nQB2EhAQZqFtpJH41I6/IAefrTWXBPAoAqTFNpxjk18ZfGYAfEHVhj/lr/AEr7Lu1LdAAM818YfGEgfEHV13bj5vX8KAOIk5NV3TNWGpq4zyKAKbAg9DSDhx9atTYJ+Wqzj5l+tAH0/F97PpVuMjqR1qkmS3vVyP3NAF2PBwMYqcPgDHWqyHCj1qSLnqaAL1u3mDGanDdiSPrVOMhQCOnfFaFqmWLPjy/WgCJ5MIxBHHes99QiQbi649Kk1TJilZQVXoD6155q+pCObyQeAcnFAHdnWIVQHcMVNa6ssuSi9B1rzqxnaeUHccZ7iuusFKqMYxQB00c7yrlm/KrkZ+ToRWZaEEADgntWtAuFz19qADbuH1qIquD+pqxKMIMfpVSQ478+1AFG8VSMADJrJmT5jnkdxWlebueMD1rMnlIHIH1oAhdvKc8fSmzTLsyDVe6nBAYE+hrPluCRkUAStMzMck89BV+2c4XPWs6IGXGFOa2LS0YgFvyoA29LySD7VtIM1n2cYhjCgc+tXkY55FAEgyW7e1TKMLg1HGwyO2aeGBPWgCxBHmQLWqPlUDGao2KfxEGrpGOc0ASJ1FXF4QD9apR8Yq4oPlrQAZ4+vNWPux4qsBufH8qmlOAF57UALHxz3qlqDfLn9Ktxk7W6VUuctxjmgCizDOc8YprMAM0HPOQB2oIXj+VADFkXoTTXGSTwc0vQ5pAOeoGaAEJ96VpMqccmlK5GRSxRbuvrQBcshti3EY71Xu5txIzwKtP+7gwBWVI/zHPFADJidmcYJNUZpizc9qsTyAD7x9qoMQQeQTQBHLI20q2cDuK5LxQ4MLFcHrXQX8uxMhuvWuY19RPb45VgMr6UAcO8gc8etfSXwxTZ4K0/A6qT+tfOpg8tiMZNfSfw8XZ4O04HPMeaAOh5IFRyHDjJ7VMCKglfLjigChMzGRhnPtXxf8Wir+PdYYDAMxxmvtS5KqTxgmviD4oTmXxzrLdxOwH0zQBzRAPpTdvPtUSvzzUoOQcUANYA8d6gkXkfWpSPn5/SnMo4x60AfSsZ3cnPWrMO0jrWfK4UYB4qW2bkcUAapUlDg8URsoOMmiAqy4J5pGGx+BmgDQtArybVwB2rpGtvLt0UJlcZz61yMTSFVCjnNdTaaqkdqsco3OoxQBkXET3D+WAGBbGK4vWvCTrqcjKg8ofMWJrtNU1Fvs8kkClWFcPqOsXV27LLKBH0Cg0AMgsoIpAFOSO4robW3wo2E4PrWBpyGc7twz0rqbMhFUNnFAF+2i2qAfwrTibCjHWqXmK+0r09ad54RcA89KALDvyRnpVKaRQSc/WormcKpbdjPWs6a9QAtkelAD7y4HOTWDfXWzJycVNd3PmnaAOe9VfsTSgMxJI9qAKKPJLnuDVmG0LMM9DWvZWcarhV+bryKvpbZkwB972oAo2VrgjaPxrobO1AUMRyKS1s/LXk/XjpVkyCMYFAEmAOmKeCNuSRms2W8AJGcVANQ2HBNAG2h+bnHtg1ZijLOoyPpWFFqIJGOord02UOm4nDHnFAGpEQowo4qdTmoEwRnHJqRc9ueKALMSnPqavoD5OPaqELHIyB0rUgcMgweaAIo49pDE0xskjJqzMwK7RwaqEHNAD1bCmoJ14zjkipM8AYpZOQBigDNdCelMKEDpk1d28Y6DNIF5JoAzXXC8g0zB9+ema0/Kz1FOW0BOT+FAFCPJIqyi4xmrP2ZQpyORSCPGBQBXvQPKABx3rLmUYrYvEygANZMi4yc55oAzp3xkZ6Vnu2TkHFW7pSTnIxWbcNsViKAM3Vbj5CwAx0Fc9cz5j2nnHSr2qXAbKisKWUhlIPfpQBRnYeYDjBzivpXwbGF8Naeo4AiWvmWQk3m3/aFfUfh5dmjWS+kK/yoA0OjY6CqkysZAVIGDU4B80k9O1QTFRIuTznpQBUvYz+8LMCNucV8K+OsHxVqfzbsztz/wACr7o1J2SCZ1GdqE4r4X8VnzdavpVGN0zEj6k0Ac8Tz1qSNiBTHXBoB6UASEZ5pAx3AY4pSeBimjqPrQB9DucqccndU9q3zEc1VyNxAPNXLCNiRz1oA1Lb5Xyf/wBVXDH5inP4VAsHHBFX7bBVQelABa7YdxfGAO9ZOt6sdgEHykdcd6u6+fs8G5Bkn0rhbm4uNrvyuenFAGndancLAyu3b1rKjnjn/wBYDgelZpmlmJLEk+9W7FNmfMG7cMAZxj3oA3rORGRVjG1T1NdHA2Y1J6AVyVgSu0YyK3TMyp0oA2vtAjTOck9qr/a8ZLcVlee2O+fSoJXd+h25oAt3+ogoVB56VjtK8rhd3HtSyR5PU0+2jPnAj8aALUNvlBnJIrVsrZpFweDjiixttzDPIrbjjWIDjp0oAhs7A5BOc1sRWBcr5UbEj2rX0G1ikh85wCSehrSn1CztVYM6LgdBQBgnR7hx95UI7VmahpV7CpKqH+laGpeLre3OY13j61h3HxAsWba6un60Ac1fPPbzHzUdT7rVP7buIAzmuzt9b0vU+PMiJPZqZeaFYXab4gI2/vJQBg2M26RT1B4IFdZaSABQp47Y7Vk2mgy22SuJB6jtWnZx7XCtx7EYoA6C0bKDPJNXlHy+lY8D4+6cYrThl3IAxoAnTgAip1kKrxxUaDjPrTsH1oAmWXPBp2d341WzzxT19zgUATbDjj8KYeOM81OnIHrionHNAEZ9+hoX6cClb8qZzz1oAk696njwaqqec1NG2JBg0AWyo2dKgZAXGBUzsNvFR5HU0AVLhMA1kXC9+Bg1f1i6FvHu/SuYm1QyudwwpoAlulCsSOawtTG5SBjI6VautRVEbLAfWsG51AFmYjcB0oAyb2B/MYNxmse4VY8/MOPWtbUb4XClB8mO9ctf+YpJPI7GgBLeVH1OJR8xZwD+dfWGmqI7G2XGMRgfpXyX4ZQ3HiGyQc5lX8ea+uoFxEg9AB+lACZ+bpUEpIflQeetTPgGoZvv/eoAy/ElwsGj3kjMFKxN1PGcV8LarJ511O24Hc5Jx65NfanxHlS28HatI5+UQNz74r4mnbe5KnP/AOugDPkUg5JqI9ausmc1WdecUARjipUXcw9c03Z3qWD74+tAHv6IGfAHGea2bBFSL3qrDF39fStCHCjv9KALkZBAFDPsUkZ4pqgEghfrUGpyqo8teD1P1oApXmol02vg5OKoXd1CLORRGC49qr3RCyb2xuPSmLE8gBHJ7mgDHRdxYqMA8+9Swg5CqMsfWtOSyBkPl/ex09ams9NZnAIIYnHSgBLGP5CD1rodNtnLI5QMPRhUul6I/mLuXAHTtXVW8cFogChc+nXNAHNyad5jOQyqc9AKZLocwjyCNvXNdI8i7MbFzn0xTBcbAc/d70AcmNLxjzMY9ad9iCqSoGBV/ULhFPy1h3OrhAVAyQemaANe0LIRtGSK1GmOwY6964y31pvNOEwCPWmz6xcRn7x2Hrg0AeraTcbdNwCQcGuO1TUAnmszdz1qv4c8SK9rJG2Sy+tcV4h1KUXs8ZztzkDtQBY1TVWJbDfhXPyXBcliTmqslwzscnNRmTFAFpZ2RwwZhz2rotJ8S3tmyfOZEB+6xrkTISKsRM2BnpQB7FoXi62ndRMTG/fPSusSW2vYgW2knoy14PasQg5O01u2Gr3dngQykD0JyKAPUbmNrdt0bbl9+tRrqpVu232NY+i+Iluz5N2MOR17GpdS0zcPNszsk7gHg0AdDBq4wOGq9FqSOB8wB7150by5syUm3Zz3qeDWHGM9DQB6KtyCD0I7Yp63AIGa5G11hRhWwPxrWgnWUAock0AdJBKCOKkd0IxjkVm27lUHv61MX3cZ460ATkA8joaYVyeKgL+h4pUmbIzzQBOq4OBT1UggmmrKO/FSIQxHzCgCY5A61BIxA5xmrTfdx1qncjIOMZ+tAHO+I5d0YGe9cvKQv5Vua8x3475rnr2ZYkJbrigDD1m4/gFY5umQFTgrT7+fdLkHOeuKz5JOTx70ASXMm5chsj09KzJiXyOxpss5RiVzVd7sEYfigDY8AWTS+L9NRRlTMP8AH+lfVMY/l6184fB1TceM7VQuRGGfP4GvpBRhaAI3++vH41HOqk9Mn1qZ1yw9qhmD71xjb3oA88+OFwbX4faiRz5ihDn3NfHQ/wBY1fWH7Rc2zwPs3YLzqMeo618psvzFgM0ADrkcCqLqcmrwkHTFRT4HSgCpnHU4pEOHGPWklI6UkP3x9aAPpiJuACPyq3A4XJPesu3clj3FWIHWSUIMA5/SgDUeURxF+wFZF27yyBxzkVpXhWWNkj+6tc7fXDK2yPIA65oAr3zkSYJBB6H0qbSzM+ByEzzkdKSEFjkqCfcVcjDBto+7npQBbxEn3SHcmr9nMUycAt2NZ4haJiONue/WtWwtt+1jwvagDWtXZo9zH8KlZseg96buwgAAAFZl/fYOM8CgC9NdogO0gt9azZ7xirktgdBWa95uz82CaydU1VY0ZN+F4BoAtajfBjtVs4rAurhFJLmqN3qvH7sfjWRPcNKxLtkmgDXbUVQsE5BGM5rKnvZXl4c4z0Bqurnd14psuEcn15oA29Bv2gv4wzna3Bq74sjzJFMvQjnFctBKyOrL2Oa7C9K3+i784ZVyPagDk9/OKbI1NOMnmmyEY+UgigBY2y3JP51dhOWAJrPByeMVbtmzIOlAHQWi5VSW4HatW3iU4OwMMZPrWXbqSy8cEVtwK4UYGP60AX4FaJNyqAcAjHWtrTNamiASRQ6Z4z2FZFuCD8wyD61ZSKMkkAqDxQB1sU9lqSbZETd6HrVO50N433wIrx9dtZMQVTlWbfgYPSuk0e6kYlZWyo/SgDDNs6y/vIcVraSDEAwRgc4610v2e1uozuAI9utMh0lUj/dMevSgCS3mBHJOcdKt7Ts4YVWitnV+h+tXo0Jxu6+9AFcgj+Gm7jtwOtXHjOPvfhTPKB5YcUARLu2/NSgt2496RkkEmUwRUvlts3YIoAlR2MfLdKp3E7ZbFWLcE5Bqhfny1Yke1AGDq6nzGkY8CuH1u83sUQ9P1rrNcn3IV6L3xXB36lXJFAGbI3OSBVSVt2TxTrmT1qg0pJwBxQBXupeCKzJpc9BV68wMg8E9KyJCQT2yaAPb/wBniySSbUL11zJGqop9M9a91B4ryL9neAr4bu5ivEk+AT3AFeudKADIzjjNRScmnbRnIpjjrk8UAeJftNyBdA01SpO6c8+mFr5lD9c9K+iP2oLrEGk24PJZ3I9sD/GvnAk+YRg4z3oAbk+YR0FNkckcnmpZV6EfpVV8+hoAibluadEMOPrT1hd8EKc/SrENpIWGRjmgD6BU7A3THrVmILDB5zEmQ8Ko7CqhQyShNvBOc1sC3RYzvG7j9KAKkUw+yb84xyR3NYFxch5S7YAJ71e1ORYo3ZcgAYxXN3BMzgK3v9KAOlsgZeQwRcdSa1IprdDsjG6T1964zTRIZNpdsdMZrprWIqNykbh0JoA1beF7icNMMnt71upAIo1GPrSaPaolojyuPMYZHtVuKMuwTByTQBTuS4TbGrMx4wBmsqTw5q1825YCiH+8cV6jpOlRW8SllDSEZJI5rTMKg8CgDxe78F6vBAWiEbyY6A1xGr+H9YgZzdWspAOcgZr6eeEFTxWXfWSSRtlRzQB8ryq8fySqVI7MKpY+Y8EAetfQeueFbO7Vt8C59cc15l4h8Gva75LXcQP4DzQBxEgJbCKRgZ5okO6LOM4p84aOQhshhwQabIcQfU0ARRnoOldnoI83RyrDjkVxifeFdv4TXfpjDryaAOLul2SOvoxGKYFGMtwKv6tamPU51YYVWz+dZt02cAcAUAIuWcBatpkKDjpVK0JZ1x0FaoAI6fSgDX0yfzIgy/eHBFb1vOxC54xXK6WGW5ODxjgV0VqxHLZBHegDZWbt3AqZZGPX8qz7XJIxyTnk1vabYmUAsDz3oAht1kdujYFdTpyHaqjsOT60lrp8MeFAwD1+takUIiHzDHpigByBkiYrkfjTrW7mjiYl888A1NIymLjIOOtVQdsYyOvAoAvW2qZZRIPqa1Le9hcDkAnpXGzTDzAAe+auwz4UMRmgDr8RyAEEUjwYX5T+BrAtbvDABuPrWkL0qo5zQBMd6NyPyq3GxaPkfnVCG/SVhuUgmr6yRlcAjNAFc48wheDWRqasN5PPvWwyLk4P61UvbYNHyetAHDak2Rt4ya5y/tWlLYTNdzf20MZyR781g6lcwx27bcbiOgoA8+1HT5c5J2gdqzDHFG+HcH2rY1y8lmGFwpHf1rjb/eCXGcdDzQBpzS2hyMiqEturFjCQcjvWS1ycYP0qP7W8bDaxHtnrQB9VfBiFbXwLZocb9zlseua7x2ITK15x8FROPBVs03V3ZufSvQpH2wli3QZoALeSQqxkAznAprSgsQ3WoIrgGBnyAMZqil0JXbac4oA8Q/aThS41bTvnwVhbjPYmvC5bSCM5ZunvXafGrX5tX8ZXq+ZiK2Pkrz029f1rzliWOSSaANUG18o4AyKqS3UA4Cc1URsP7Uybr0FAFyO8AfhRge1Nlu3aQdqpqOO9ODDcB70AfSEETFWOPn7Z7VB9ruIHO8ZRRitSEKbVipwc027jTywMc4yaAOU1SY3EYIBAPXNYasIpcE9eK6+eKGWLCr8wPNYN3HGJljSPe+ewoAsaVGPMMjYx0xXSaejznAGAp4FYlnA5Kl+g7Cu68M2ivKgIyD1FAF5FMYQnAIHArU0ZWuLqN2A+U5NUtUkjjkIXjAxSaNeeU/TgnrQB6PEcinnmsWw1eN5hA42SHlQehrXVxgc0APPAqrMm7NWSwqCU8UAZV1ECDn8qwNRs1aM7lGDXQ3TgA1l3DBztHIoA8S+IOgG3Y3sEfy7sOPT3rh5xtjQfWvojX9MS/wBNnidchxjpXgOsQfZrmWJvvxtt20AUkNehfD2LzdPl7/Oa86Q4+bHtivU/hoirpQ3dXJNAHK+O4fs2pkKfvKDxXISHJ612HxMmDayEU/dTmuLB3Z9aALdkoHJrRR+gqhaKQi9M+9WFYhxyBzQBtaT/AMfiAcnFdFtAZeBxya5zRAz3inqcVvsy7hzz3oA1bQfMvv2rqbMmO23OvXoK5SybMw2/LW7czsoRUOTigDdsbhWlBbGRwMHNa0zEhCvPrXJ6fKSQdozmuojY+WuByf5UATvxEdxAyMis+5lKIG3Z71Ley4thjg1gX92yfKGBUdfWgBDc5kXIIOSSRVlLtQOOucc1y7XErP8AxAAkinfaWhjXe2XY5wfSgDqItQ2Kx/lUsOqScZYc9649Lxmfj7vtUqXxBIPGKAO2t9TGcg4q+uoHZnPPqK4SG7OEY5z9auJqfRRyc5xQB3NvdM7qVYmrV1PiMkGuY0+7GwtjBHQVFd6m0qkMSpHcUAN1mcuHbOcCuU1FysIz6Y4q7d3rYbJzmsG/vvl65PQigDJvVLIxA+auZvVOZBjBHUGujkuPmwcVnavHFLZyTJxIeD70AcNcMd3X6Vc8MWjapq8FupxuOWb0Xv8A4VSu1Kt1zzXo3wF0A6j4gNy8e+OIdO1AH0P4PtRp/h+C3CBNq/d7r7H8Kv6jeRxW7KxxlcfnVyK0jjLsgAaQ5Pua57VbBru+hEchXEm9sdCBQBF4gvBpHh6WYydBgEjOM+1c1ofjK1eyuN5zOsTSgYwGUeldh4j09L2wFs0oU8Fc9z6V5H8R9NtfCOgXlxHn7TcQ/Z4iOig9RQB4L4iuxqGr3dzn/WSs361mMu38aRySzDvTv4RQBBnkmmscilfOT6VETgnFAD8/LUYPzjBoByKav3h9aAPpG9vvscflxFfm696of29IVAeIFc8nNY9/cMl0zMMqScD1pIpUaP5iqjNAG0dQBRmjjAJ/SqzeYQXjRS55qKK5tlGVYMR1FXrWZHIC4AHJoAl0kSTXSqRgE4xXoOmg2BwCGc9h2rndBhFxcLHGgAbvjmurlsvL1D5FPQZzQBTv0Mqk45JzUNqCgOcjFaF5t34GOOKrj7pxjmgCvLcPM5i37ZVOUfOMV0/hnxCl4rW87gXcfDD+97iuK1ZCsodDjbzms5mhlulnjnMFwvO4HHNAHtXnrt6iq9xcqqk5GK8vvvEus2lvE0TRzqerEVzWrePdSbMalFA4JA/WgD0rW9ehs1clwMUng27GtxzXS5Me/APY14dDLfeINYgtpJWZp3A44AFfSnhbSYtL0qCzgUKiL+Z70ANurRRGwx1FfNnj+0MXiW+CxsPnznaa+rpEjWJ8gcDrXAazplrd3UsrxqxY5yRzQB82fZ50wTFIFPfaa9Q8Esq6LG6nlRzXWSaRb7ShiT2yKwtaS10iylaIrEgGSBxk0AeV+Mr37Zr11Ip4U7eaxhx9afdN508kjZyzFs/jTE5egC/EQAPpSlssOeM1WEmyrNiVmmCsMCgDofDymLMjfRa14zvckcEGqllGvkhQRgDrV23ADdeB3oAv2h46855xW5KC6RMg4AFYlun7wlGGAc8d66aGHzbBfLHXjNADNOUmWMEfKTXR28w80L2HQVkWdv5PzZ3YBAqezdldixycflQBb1mQeVGeQvfHauTuroPJIByOQDW3q8jOiKnfqDXM3DFCPlGfbtQBVuJmjcAtnPpVe4uNxY5GDxUtwwfJIGfX1rPePbJ/sgZ4oAtq5VgpOAO4pqynncxwTzVEH7uCfqacpLHO0sKANVLkrEcMTVrT5WlnIPG3ismOFnUZOOa0bT904YtncaAOn87y7ZmBIC9feubuNSd2cBjj2Nal6xGisQ2Mnk1xFzcCOQjPfr60Aal1e4jAO7npWXPeMynjIHbFZ0t/kFic4PHtVU3JdiXc/SgCxJPuycHJ6VS1W98u3ESnryaimvto2JnA71l3TbiwPXv7UAUyklzcIkSlpC2MAZ5PSvqT4PeFJfDegQfal23Eyh3H92uI+B/giGaSPWdTjLsT/o8ZHGP75r399kcRBwAPSgCrPdLErKxIIHWsfSLv7XcT3AwYw21T61X1uUlDbQ/M8hwRnkA96vLpsdrooghYo2wgN7kdaAIHvrfU7wxRtkQsCx6YI6V4d+0XrqXNzZ6VbsH8gGSQg9zwAa6G2tLjwv8AadQ1HUMx25d5VDHEp5wK8C1nVpNT1Oe7mbLyyEn6dhQBiSfK2B1703zDmpLkgvlRgVXfOaAHNioGI3U7dSHBoAa3tTR99frTm7Ui/eH1oA931+OKaNWiDAjPTsaw7e28wHzCxI7V0l0kYtGGcE9656KRopGDHjNAFlLPaVC+tattamEqXOO/FVbe4XaONwY8Va8wsQWJ2+lAHa+F7uGO/gBOASBk11OrXDLeHYPlx1rzK3kICqhOBzn0rs7G+a6t0WRgSowD60AXJDwGxgH1qOMZXrjmnsf3e1hkdajhGTzwD29KAKmrR7rcsBwO1cfexkEjFd3Jl43XseK5S7tiLkg5IHzUAM09y1q9sxJZU459a4m7iKzuCDkEiuv0yUJqJLn73H0qj4jsfs9+pRDsl6H3oAu/C7TQdZW7kGVj+Ucd698gkCRL9K8hhx4d8NiTA8zG4+7VHb/E8pZGNrVzIBwc8CgDsPG3jqx0aX7I0m+UjkLzt+tcHP8AESxKkhZD74rzvVbmW/vJrmZi0kjljms5xnCkDFAHoN78Q4yMW8Luw6Z4riPEOtXmsPmdtsf9wdKoso5AXpUb5x6UAU2XrzzQqkDOKe/3uKcxIFAEDnJFaelRHyt5XqcCqSRtLIFx1P6V0FrGQFQYwKALUDfMNuRWvBIChDvg/SqcMAAO4Ecdanhixg44HvQBu2YAKgrkeorsdLh/0QCPpnpXCWUxH8q6Wyv3FqERsN7UAad9MIi2B049KzRe4Yqv596W5m89t0oJ47VUCFmOygC3cS7kBDHGKxpyzOSvatJlPQrxVGVcvjGDnNAGdz/EAT6U2NSc/KOetWZFAbjAIp4UAfMMUAUhZCXIChc8A1dtdJdQc5+oqSJkjcDIB61r2DiQABs5oAwbq3MRVwMDPTNJEDsBz3611GoWStZZK5INYawLHIOCFFAFjVyYNDHIIYV5xqkwLL1wK7PxNqEZsPKXJ2+nauAvLhNu+XhR0NAFKeTy1Y7sE81XWfJNVbmcTSks3HQClSVUx3oAnmlABziuu+GPhI65fz315DJLY2a+Y6IOZG7LXEeYZ7lI4sszHAAFfW/w00GLR/CdnAy/vJYg8v1NAGh4bLCwVmthbAjCRd1XHp2rD8U+NbPTLw2ckgEvYN3rptalXTrF5Q4VVAGD6eleXyeFY/GWrpPc/LErZ3ofvD0oA7HwsBdbr6Ri8bfc3dq6J5S5JUDaB0x3qnBposbFbO1XbAikLn1ryP4h+PbzwvpyWwuB/abjBiXkoOeaAOU/aD1qI66NNsrjcqgPMinjdwMGvGCfmGTzUl7dzX11LPdSGSeRizuepb1qsWOaAJC2RmmOeaXPFMI70ANPJpuRT6izzQAp60KfmH1pKAPmH1oA9+vADEufWsq5tVcblYZrUdxhw5+XpVJkDAKrd80AVrBmjk2c+2a1VUttGfqTVIRbXB9+tOdpJJMJkgUAbUborELgqRjPrW7psiomzOAOfpXIQO7gRk7TWnZO8T7WckDrQB3sM8dxah1bDgdM9aRDnH6mubtpXTgN9Oa2LZy6L/eoAuE9RjrVLUbVTE8pYjjHSrkaMG55J/SlusSW+zHyk8+tAHC3C7X+QbT/AHq2NG1CzmdI9RUEx/dLdCaS/sikhwPlrHuofKlyq96AJ/GmrR38i21vkwR9T6muSaJTyBge9bFzAzsXA+U81UMe3+HFAGRLEc9eKhaIEZAJx3rWkC4JIqnIV6AGgDMkTbkc1XlBI46Vcm75qpJ8vpQBU2YfI6Uj9ae0ijvUMsi5znmgC7pzou7JG49K2rZhGVLAfWuWiJ3jBFbNpqW1dkyhsUAdEbvfGFGAPapIZGyeAfrWXb3FuQGJ2g+h6fhV6K6hwQJ1JxxlcGgDSiKgDLKM+9XILmOOT7/SudaV9+S6Ffaq8l+wJC5oA7FdQi/ic4q3BdRmTiQdetcBJfk8YNOiv3DKA/OeM0Aeoq8brgSDP1qpdwkHIwfpXPaXelnGWzWlczFoeG5x60AQz8HLLx2+tRCQIG3HOelVHvWjZkbkCoH1BQx3D8RQBad2O7nnPNWtNumjuo13HHfNUIpoZQWVtrY796fbk+ZuALkHqKAPQ5pV+xDLDBFc5eAk4Xle+O1TyySG0j4OAOaoyXICDdwQO9AHNay2zerHO4cg+leb67eATGEEbVPSur8R6qWuW2L93gV5vqbl7uRic7jQBL9oGCe/tTRcSSOqoMknAA6mq0ETzSrHGpZ2OAMZJPYCvd/hr8KkimtrvXpStxIA8VuBnA9WoAf8EfhvLfXCarrCFYFOUUg5avotIktV2jAUAD8qZZxQ2NqkUeFRBj6CsnWdbt932OGUGc8+6igDF8b3320pYQxs25xuYcge1aPh9I9I0yNJI/LfPC1W0CBzelyoaNOTJj7xqn8QNYt7GBIrsKkTclz/AOgigCz4w8V2+g+Grm/Mit8pEeD1Y9K+MPEOrz6vqk91PIztIxOSc8V3XxX8XpqIh0qwIFrA2+Q/3nP+GK8wPQcY9qAHq3QelOqKng8UAOpS2RTM0UAK/AqOnHOOabQAE0meR9aGpB94D3oA9uvJSrgA8mpbQRyNyW4HUVWvTmUkAZHSo7aULuAOPpQBrPbQhQRI1Bngt4G2jJz1ql5pC5yM4rMmlkVgpOcnJxQBsW10kk2T8rA1pRSCRyqE7vWsOxtBgOWPPXmrsl7HZkbBkjqaAOiszz6mtmyleM5b0xXE2WpLJJuVjnriui028klPzjAPSgDq43Jj3uMUZ5ye9RwOGhCnBOOlPb5UGeaAGyIsn3ug71jX9hySQTnoa11yQOOCaeQXXBAI9KAORa2Matu+70rOuI1xwOMV2lzbRyKygYaua1G3MJZT0oA564UAnFZ8qrkkitO6UjNZkwIBPSgChdlFGRWLcyktwQKv6hNhuTxWLO+45oAZNL1xVZ5MjNJI2GqInLYoA0bU5AI5NaCwPI3yiqunqodf4q34osj0+lAFRbJwMlgtSCDY2fObPsK0I4k6Nn0pssO2THbFAFcOF6SHOPSlt2jY/O7L+FPMQwcDmmLDg96AJJYIpB+7nBHuMVXFmwkBEqnmp2jB4/pVy0sAX6k4oA0dIglQgEr9c1tTRsUBGDx61Rgj2MFUkCrE6FlODzQBnXULEtvDZ9fWqLwtk5JwBjFajCZRyflFRsfNCgqp/DFAFGCGRFwSMH5qntrsxsVztA5J9asz26CEESbW+vFVXs3RBIfmB7igDprK68+yyp+76msPU9RESSBmyR096doshgcRyYAfgDNVPENoczKRnuMUAcBrd+0skmF2qelct80jbQrE7hwBkmujv4C7so+8eOmePp617J8GPhXcWsa69rFqj3LDNrby8hPRyPWgCP4G/CsvFFruvIyOTm3tzxx/eP8ASve9RFvZW4cjG0bQcUiMbK3zOdjYwxHFZGp6stxA0DFcN91f71AGV4o1uW2s1ktcvJ/BHnqO9cg4uNadDpshW6YhnlPRR3z/AIVs2mj3lzdyIrCQMclmPCD0xXaWeiWtnYGG0jSJQOSB1Pc0AZ9hdKLRbW3cLIoCFj3b1rk/jJqWl6b4OmbU2WW9PFuB95n7fhXKa74hufDU+pX2tTC2yxjsrRWBdxk/Njt+NeEeKPEl/wCItRa61CZnboik5VB6D/GgDJuZWmuJHc5Zjkn1J61EeetIPpS0ABqQcimrT+1ADe9Kw5pB1pX60ANPvTe9OPSm0AFIB84+tLQPvj60Aeu3TsZ3II5p4tH2A71ANVtRwsxdTyarm9KrtLdKANKO1lPyscL/AHvWlMMNuC7uGNZ63jmMMrEAepqldTPM3I+T1zQBrG5JyFPy9gKazGdRkgbePrWRFMw2r71fSXdyBgelAGnZoBLu2kYGK6CxulhIySVFc1azYbGRyO9atph9pJ+X+dAHf6deRyRocjnpWq5DpnINcDDO8TqUYY9K6G2vtyA7vmoA2lBHfFJ8gHB5zVOK6BYAkfSniQFsZ60ASBsZLck1k63FkBgO1aasO9VdTAeA45xQBxd2Mbs1h6jJ5cZOOK6G/TH0rkdYmLOy9qAMe8k3n8azJyQ2KtTkliRVVlLEmgCpIfnoR18wDAqSVOM96qkEP9aAN+yA+Q11NggMedpJNclpLCRVGTuXg11lgW8raDnFAFxFwvK8Dk05UQkMwOO9MVm+QHOB606Rjklvu9aAHNbwMclWzng5xVy30qGQqGBGearQqZZUHPrXRW0HlqGIPzUAUm0iNcCMnkZye1WbDToirsp+YHnIrVit9yNIQSwXFV7EFZJgTwec+9AFN7VVlwrAVMsA2kFqqXLESEhuhz0qVJ9wHznIoAlNiGQfOD/SoJrBBGT5hBz6Ust0yElWznqKje6dkO4igCBrSNEYSMWB7gVraDbQvmEv07MOKw/tOWO4kr7Gt3wwQ94VDHG3OCaAKF9pCw3oZdq88YbNXdZ0x5LZGK7w6Y4qxqKOdRAVOe2RXpngvRxLDDPcRKY05AYcE0AcX8MPhbEtxHrOvJuOd0Nuw/JmFeyDy4hjaAB6VZ8sYwOMVHJEpXBFAHNeJboPGQEyB90f3q4ayVYdZhW9kZo5W4x/yzr0bWNOFzFjbuYHKnuDXJwaaRqJ88CRv43x09qANuysVtMyQtuDHJPUgVxPxT+Jdp4VsHjgPmX7KfLTOAM9zXT+IdRtNA0Wa4nuFRIl3sS36V8X+Ltcn13XLu8mdm3OdoY5wucgUAVNc1a71m/lur+VpZHJILHJA9Kz80mMCgUALRR2ooAKkB4qOnCgBaKB1oIxQAUDBzkikPSkHWgAPWhfvD60HrQv3x9aAPUrguzsGAwDiqZhLSBnbC1PfXytK20ZzzWc11lgNxx1xQBpS+UgEeMZrMlBL4U8VGbjzSeeR0pkN2GuPLY8Dv70AXo1GwZHIq1EvmoCvSoUkjxgnJqa0J3sF4HWgAZmSTCE5HWte3ulVQD1xnArOZMsT0PrSBADy1AHQ6XeeZcgPz6V0QkDkAcfSuR0hQHLnOB05rZjugBgc0Ab0Uj+/HerXnH8RWLa3rcBhkVbF0uM4zigDYhkyR61M5DDGeD1rGtroMT1FTNdkn5BxQBi+Ix5Tsi/hXA6mPnP1rvtZ/0mJmPJFcJqI+fp3oAx26YIqN1CjFTsOT1NRyLwD6igCkwBJBqGRASKsMvzVE6kk4oAm0sFbkFRnmu30oB3A6cVx+k83oPAAr0DSYowwJHJ5oAtxWe8KuOvH1qePR3YgjO0ce1ammxglSqggZwKvx3UcSeW20N3oAgtNJC7SuNxFaBtfKGGx7+1TadKGnVQobnPWtG6iDqMAZY80AUxGq2ZIySR2rMSIrDIccmugMRNqVBXHT8KxLwtFEQPujpxQBz2oE7yoI4GfxqLzMKoYfNTb1iWByTzzVcOxYFgfQ59KAJWcHpzzmoZyCjMWwBURfDOwPQ4AqjqNw624RD3yaAJJbyJAVB5IrrvBMiTEkfexjNebRuX6dSfyr0j4XadPqGorAgOCuSccAe9AHoOkeH31LUBMRiHHzN6CvSbWBLeFI41wijAFR6dZx2dqsMI+VR19atYoATtSHvS0h4oAjcA5zise/ktLGCa6umRI41LMzcAVrTOqKXYgKASSTjFfMPx8+IT6uraLo0pGno37+VTjzSOw9qAOB+L3jg+Itbnh053XTlfCkn/AFnvj0rzj24qadSWy2OmMgY4qPFADTzmkAp2KSgAopQM0EYoASnZptFADu1OU/LzSDBGDQeOO1ACMMmkIxTuO1JjNACYzT4h84+tCrUkaYKkDPNAHR30zbyysRioobg+WxZs0y7JYnFVJHKREDmgBxum87IztPTmnQSMsmSeM5rNLE8AmpIpgvy9TQB1mnMshVuorYjkSN8L97FchYyvGAd2Aa6DT5g+N3X1oA09wY8rzUNzwQM8jvSvLtAwecdaqSyZYZ9KAL1tM8HO7P41dh1LA+ZcnHWufDkkgcCo/PdZDkgA9qAOvs9QBfB43e9bVvKGHLYrzWa8K4KcEVvaLqrSxqZO3rQB3K4WInPFRmU9B9ajt7hJYMnpSOB1X1oAjmc5J65rmtbtNrb1+6xro7hSct61XeITxmPIB96AOKkhK8KO1VJUynH41u39uYnYYPXFZcqDcBigDMZBuNQuuOnFaEkfccVXMBZfXmgCzoUW696EgV21k4BUAc571heHbLy42kdTuJ4rpbSIb9x4A/nQB0Fkf3Lt044I7VUkdS+OSfUVoWsDjSww5JP51SuI2Dg8j8KANjSiPPVlBAIxXSyAbVUkFu1c7olu25H7EEk11KKTgtgn+E0AMmH+jsoBBxjNczqkmRjPI4rp70GKDI5PWuL1BzLK69Oc5oAxLwHGScA5NUXc7cE5Y8cVrXa5QbjhR3rIdiA20fMB1NAFmKOARSM43Mqng+uK5i9kMrlcHBrqfsr/AGGaUsPu7awLOykub5YY0Lu2FAXuc0AO8MaLc6tqaWtsjPI7AKB/npX1D4H8L2/hvSlt48PcMMyy45ZvQe1Zvw48HQ+G9NEkiK2oTLmR/wC5/siu3AwKAFHrQT60hOKDzkUAJkZz2qKaRUVmZgqqMkntUOpXkVjayTzMFiQZYk9K8J+J/wATGvLOXTtLYxws213H3nHoPSgBnxj+JwnSTR9BlJhJKzTocbz/AHV9q8EmkExw7ZJ/KrF/cmTfk8ngkcVm8tLwOMflQBQ1BERyM9Pas+tG+bduB6jvVDb70AJTSKWg0AC9KCKBSjrQA0igCg9aUE4oAaODxSnmkooAKkQ80irkU5VxmgB4HI5q5aRGSVFXnJHaooE3YznNdDoNsDKGIxtoAzDcKc/WhoxsbvxxVSN/nIPIzV6BS2UPORwaAMpUO/5qnSAD5ttTy2pSTuKXDA45xQA+LA6jgdq3dIdQ2MdOaw4YyGz/AFrasUEQXH1oA1ZHyuT6cVQbHmZyfrVp8MhJ6VCUDqSTz0IoAcFXy2JOfeqk6c7qQ3BAMRGOe9RXMjZHOaAHZVuNtW7SVYhgVnq52571NE2Fz3oA6Cy1cxMEByh65NdBDfiZV2EfnXARl93GOa3NKkZWUk0AdhvLxioDwRg4p1qQee2OlSNDn1560AVbu386MtjOBXNXduVc12MasvGPaquoad5oMiLnjpQBxZjK/d6+9XdPsxcSqhX6mtFtNJI4rZ0rSjAvmOMH0oAmtrEDaEXCqMYqZbfyz35B4/DrWhaxfKueTzmrhthIQMcdPqKALmkqrWqo3zNjgVZewWbkJggY5pLKExdACy9PcVqB9sRZhtPpQAy1tjbYU49eO1a1qFKKWI3CsKSV2mJZsJipLaZs4yeeKANDWJIxAx3cgVws2SzEknqRXTatkwcHPNc9cRbsA/dxQBmytuh29Tg5qvFbbiQF6jn86vzwFV+UdqIo2jkGenTFAD9Us2TSFSIgM55Bqt4IsWTWrSYgERyhj+ddJq9sxtLVfbHHepNFtxbSh8AAjnAoA9wiYMgYdCM04muc8OaqJbcRyMWI4BPpW+JVbgEUAR/aEMpUGmXd/b2kDSzyqiIMkmq+qNDbW0szusYAJJJrwzxr4le7My28reWCeM9aANP4sePIr6yex0ly0ef3j+vtXht6WmKsckkd61pfNuJJGfIXGQc1h396tsCq/M3bNAFCeA5O4YFU53W3iba2WPAFLcXc0wHNZzB5CSxyaAK0zHPPXvUD9anmXHWoXxQBHnNLRSUAGMdKUUUmcUAIw496OaCc9aVeDzQA2lx60/ZzS7ckUAKvSp4o880yJC3ar9vGMDIoAW3TaRxnFdRpKYjD4wSRWNb2+X2hSDXS28DRpHxwPWgDgEUpIeD1rXgO0pgc1ViRTuyO9aMCLtzjmgC/JFFLHufGcVU8iJX5zipOqYJP51Cw+SgBnlgyEJgitKGNvLXaMjuaq2aL1xW1Co8rGOKAM5ZGRypBINSyS7QFCc+tWGRfSqlwMScUANuYw67h96qjjjBPIq4earEDJ+tAEUKsXwRUpjCAjmpkUBgQOavJGrIpIyaAKljGJD9K3II0QDaNxNUrGJPNxt71uJEgkXC9qANbSVAUetawhDnI54qlpSLnpW9bIvpQBRS1y/IxV2G0HAA5q9HGpPIqcoo6DHFAGY2jrMxdABjqMUPBtwuMDIFdJaKPs7HHPFQ3MaddooAwEhMcuQv5VciX5/mOD9akCASEAfrTwoyOO1AE0CleQ4xjkVJIwZcDn8aqoOAe+KimJUrtJGaALypuBBIIFXLWEFwRwKz7cZY59BWxZqBMgFABc2paMkL1rDuLUqflXAArr3AxWVeIu5zjnNAHMSxBtuV4znpTVt0EhyeOvStOYAy47VUZQA+B2oA6KWzW+0i3mtxl4hyBVWxgnll2JEygH0o8LzypdhFchMdO1dFfzSRglG25HOBQBLbW62cJd2+Yc7RWJe69dLcrJFIybT+GKuW8jyW5Z2JOO9Y18o85hjigDP8AFOv3mpqqSyEoo+4owPrXnurricPn5WHIHau11KNPKY45FcjrajyScdKAOZ1i9EMbBcAAVxtxdCWQ55rY8RgbmrmSo+b/ABoAtmQBRyAfSqlzKB93AqJulRSKDjOfzoArySbmb0qMgmrIjX0pNi+lAFYg4pMVZKLjpTdi+lAEGDRip9i46UojUjkUAV6kjGSM1L5a+lSxxrgcdqAI9nT0p4QntVtY1JXjtUqRr6UAVoI8HAHNaVvDnt05pIY0DdK2LCNS4BFAGlo+nh4VmYHjtip7lj91RWiP3cUSp8q46CqMyD5TjnNAH//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: ERCP in Paediatric Practice: Diagnosis and Treatment, Isis Medical Media LTD, Oxford University Press, UK 1997. Copyright &copy;1997 Oxford University Press.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_15_11504=[""].join("\n");
var outline_f11_15_11504=null;
var title_f11_15_11505="Down syndrome facies";
var content_f11_15_11505=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F64030&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F64030&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 549px\">",
"   <div class=\"ttl\">",
"    Down syndrome facies",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 529px; height: 301px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Characteristic facial features of Down syndrome depicted in a term (A) and preterm (B) infant include: epicanthal folds, slanted palpebral fissures, flat nasal bridge, and protruding tongue.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Clark DA. Atlas of Neonatology, WB Saunders, Philadelphia 2000. Copyright &copy; 2000 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_15_11505=[""].join("\n");
var outline_f11_15_11505=null;
var title_f11_15_11506="Selective media";
var content_f11_15_11506=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F74516&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F74516&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Legionella on BCYE",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 312px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Parallel cultures of Legionella on blood (left) and buffered charcoal-yeast extract (BCYE) agar medium (right). Legionella only rarely grows on blood agar; it is best isolated on BCYE.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Harriet Provine.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_15_11506=[""].join("\n");
var outline_f11_15_11506=null;
var title_f11_15_11507="Uterosacral ligaments";
var content_f11_15_11507=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F63102&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F63102&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 501px\">",
"   <div class=\"ttl\">",
"    Uterosacral ligaments and endopelvic fascia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 481px; height: 365px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The cervix measures approximately 2.5 cm in height. Anteriorly (A) the cervix is separated from the bladder by the endopelvic fascia (arrow). Posteriorly (B) the cervix lies below the uterosacral ligaments and is covered with peritoneum, which reflects off the posterior vagina (cul-de-sac).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Baggish, MS, Valle, RF, Guedj, H. Hysteroscopy: Visual Perspectives of Uterine Anatomy, Physiology and Pathology. Philadelphia: Lippincott Williams &amp; Wilkins, 2007. Copyright &copy; 2007 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_15_11507=[""].join("\n");
var outline_f11_15_11507=null;
var title_f11_15_11508="Skin appearance post injection";
var content_f11_15_11508=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F69986&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F69986&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Central blanching and peau d'orange appearance of skin after intralesional injection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 294px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Mosby, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_15_11508=[""].join("\n");
var outline_f11_15_11508=null;
var title_f11_15_11509="Dimenhydrinate: Pediatric drug information";
var content_f11_15_11509=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Dimenhydrinate: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?11/46/12006?source=see_link\">",
"    see \"Dimenhydrinate: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?33/50/34596?source=see_link\">",
"    see \"Dimenhydrinate: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F160747\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Dramamine&reg;  for kids [OTC];",
"     </li>",
"     <li>",
"      Dramamine&reg; [OTC];",
"     </li>",
"     <li>",
"      Driminate [OTC];",
"     </li>",
"     <li>",
"      TripTone&reg; [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F160748\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Dimenhydrinate&reg; [OTC];",
"     </li>",
"     <li>",
"      Children&rsquo;s Motion Sickness Liquid [OTC];",
"     </li>",
"     <li>",
"      Dimenhydrinate Injection;",
"     </li>",
"     <li>",
"      Dinate&reg; [OTC];",
"     </li>",
"     <li>",
"      Gravol IM;",
"     </li>",
"     <li>",
"      Gravol&reg; [OTC];",
"     </li>",
"     <li>",
"      Jamp-Dimenhydrinate [OTC];",
"     </li>",
"     <li>",
"      Nauseatol [OTC];",
"     </li>",
"     <li>",
"      Novo-Dimenate [OTC];",
"     </li>",
"     <li>",
"      PMS-Dimenhydrinate [OTC];",
"     </li>",
"     <li>",
"      Sandoz-Dimenhydrinate [OTC];",
"     </li>",
"     <li>",
"      Travel Tabs [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1057917\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antiemetic",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antihistamine",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1057912\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?11/46/12006?source=see_link\">",
"      see \"Dimenhydrinate: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Children 2-5 years:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     12.5-25 mg every 6-8 hours; maximum dose: 75 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     <b>",
"      or",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     5 mg/kg/day or 150 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /day in 4 divided doses, not to exceed 75 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.M.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     1.25 mg/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     <b>",
"      or",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     37.5 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     4 times/day; maximum: 75 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children: 6-12 years:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     25-50 mg every 6-8 hours; maximum dose: 150 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     <b>",
"      or",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     5 mg/kg/day or 150 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /day in 4 divided doses, not to exceed 150 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.M.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     1.25 mg /kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     <b>",
"      or",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     37.5 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     4 times/day; maximum: 150 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children &ge;12 years and Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral: 50-100 mg every 4-6 hours, not to exceed 400 mg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.M., I.V.: 50-100 mg every 4 hours",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F160736\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution: 50 mg/mL (1 mL) [contains benzyl alcohol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 50 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dramamine&reg;: 50 mg [scored]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Driminate: 50 mg [scored]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     TripTone&reg;: 50 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, chewable, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dramamine&reg;: 50 mg [scored; contains phenylalanine 0.84 mg/tablet; orange flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dramamine&reg;  for kids: 25 mg [scored; dye free; contains phenylalanine 0.84 mg/tablet; grape flavor]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F160724\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Excludes chewable tablet",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1057921\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral: Administer with food or water",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Parenteral: Using the I.V. route in children is not recommended by the manufacturer; administer I.M. Do not inject intra-arterially. Must dilute each 50 mg in 10 mL of NS for I.V. administration.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1057920\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment and prevention of nausea, vertigo, and vomiting associated with motion sickness (oral tablets: FDA approved in children &ge;2 years and adults; I.V. product: FDA approved in infants, children, and adults)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F160790\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       DimenhyDRINATE may be confused with diphenhydrAMINE",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      BEERS Criteria medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This drug may be potentially inappropriate for use in geriatric patients (Quality of evidence - varies based on comorbidity; Strength of recommendation - varies based on comorbidity)",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F160789\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Dizziness, drowsiness, excitation, headache, insomnia, lassitude, nervousness, restlessness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Anorexia, epigastric distress, nausea, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Dysuria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Blurred vision",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Thickening of bronchial secretions",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1057925\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to dimenhydrinate or any component, neonates (injection contains benzyl alcohol)",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1057911\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with a history of seizure disorder; may produce excitation in the young child; use with caution in any condition which may be aggravated by anticholinergic symptoms such as prostatic hypertrophy, asthma, bladder neck obstruction, narrow-angle glaucoma, etc; chewable tablets contain aspartame which is metabolized to phenylalanine and must be used with caution in patients with phenylketonuria; use caution if used in conjunction with antibiotics that have the potential to cause ototoxicity (dimenhydrinate may mask symptoms of ototoxicity); do not inject intra-arterially; vials contain benzyl alcohol as a preservative; benzyl alcohol may cause allergic reactions in susceptible individuals; large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (\"gasping syndrome\") in neonates; the \"gasping syndrome\" consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension, and cardiovascular collapse; avoid use of vials containing benzyl alcohol in neonates",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1057910\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Chewable tablets contain tartrazine which may cause allergic reactions in susceptible individuals",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299204\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F160732\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors (Central): Anticholinergics may diminish the therapeutic effect of Acetylcholinesterase Inhibitors (Central). Acetylcholinesterase Inhibitors (Central) may diminish the therapeutic effect of Anticholinergics. If the anticholinergic action is a side effect of the agent, the result may be beneficial.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aclidinium: May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: May diminish the sedative effect of Antihistamines.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticholinergics: May enhance the adverse/toxic effect of other Anticholinergics.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Benzylpenicilloyl Polylysine: Antihistamines may diminish the diagnostic effect of Benzylpenicilloyl Polylysine.  Management: Suspend systemic H1 antagonists for benzylpenicilloyl-polylysine skin testing and delay testing until systemic antihistaminic effects have dissipated. A histamine skin test may be used to assess persistent antihistaminic effects.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Betahistine: Antihistamines may diminish the therapeutic effect of Betahistine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: CNS Depressants may enhance the CNS depressant effect of Buprenorphine.  Management: Consider reduced doses of CNS depressants used in combination with buprenorphine.  Consider avoiding other CNS depressants in patients thought to be at high risk of buprenorphine overuse or self-injection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hyaluronidase: Antihistamines may diminish the therapeutic effect of Hyaluronidase.  Management: Patients receiving antihistamines (particularly at larger doses) may not experience the desired clinical response to standard doses of hyaluronidase.  Larger doses of hyaluronidase may be required.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ipratropium (Oral Inhalation): May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrimeprazine: CNS Depressants may enhance the CNS depressant effect of Methotrimeprazine. Methotrimeprazine may enhance the CNS depressant effect of CNS Depressants.  Management: Reduce adult dose of CNS depressant agents by 50% with initiation of concomitant methotrimeprazine therapy. Further CNS depressant dosage adjustments should be initiated only after clinically effective methotrimeprazine dose is established.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramlintide: May enhance the anticholinergic effect of Anticholinergics. These effects are specific to the GI tract.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: CNS Depressants may enhance the adverse/toxic effect of Selective Serotonin Reuptake Inhibitors. Specifically, the risk of psychomotor impairment may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tiotropium: Anticholinergics may enhance the anticholinergic effect of Tiotropium.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F160733\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F14446199\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events have not been observed in animal reproduction studies. The risk of fetal abnormalities was not increased following maternal use of dimenhydrinate during any trimester of pregnancy. Dimenhydrinate is recommended for the treatment of nausea and vomiting of pregnancy. Dimenhydrinate may have an oxytocic effect if used during labor.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1057909\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Competes with histamine for H",
"     <sub>",
"      1",
"     </sub>",
"     -receptor sites on effector cells in the GI tract, blood vessels, and respiratory tract; diminishes vestibular stimulation and depresses labyrinthine function through its central anticholinergic activity; consists of equimolar proportions of diphenhydramine and chlorotheophylline",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1057923\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Oral: Within 15-30 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: ~3-6 hours",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1057924\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Well absorbed from the GI tract",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Extensive in the liver",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1057916\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?33/50/34596?source=see_link\">",
"      see \"Dimenhydrinate: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May cause drowsiness and impair ability to perform activities requiring mental alertness or physical coordination; may cause dry mouth. May rarely cause photosensitivity reactions (eg, exposure to sunlight may cause severe sunburn, skin rash, redness, or itching); avoid direct exposure to sunlight.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13234 Version 41.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-220.255.2.138-02C9EFC5AA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_15_11509=[""].join("\n");
var outline_f11_15_11509=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F160747\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F160748\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057917\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057912\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F160736\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F160724\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057921\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057920\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F160790\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F160789\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057925\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057911\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057910\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299204\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F160732\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F160733\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14446199\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057909\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057923\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057924\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1057916\">",
"      Patient Information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13234\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13234|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?11/46/12006?source=related_link\">",
"      Dimenhydrinate: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?33/50/34596?source=related_link\">",
"      Dimenhydrinate: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_15_11510="Management and sequelae of sexual abuse in children and adolescents";
var content_f11_15_11510=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Management and sequelae of sexual abuse in children and adolescents",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/15/11510/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/15/11510/contributors\">",
"     Kirsten Bechtel, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/15/11510/contributors\">",
"     Berkeley L Bennett, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/15/11510/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/15/11510/contributors\">",
"     Daniel M Lindberg, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/15/11510/contributors\">",
"     Amy B Middleman, MD, MPH, MS Ed",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/15/11510/contributors\">",
"     Jan E Drutz, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/15/11510/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/15/11510/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/15/11510/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sexual abuse occurs when a child engages in sexual activity for which he or she cannot give consent, is unprepared for developmentally, and cannot comprehend. This includes fondling and all forms of oral-genital, genital, or anal contact with the child (whether the victim is clothed or unclothed), as well as non-touching abuses such as exhibitionism, voyeurism, or involving the child in pornography [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11510/abstract/1-3\">",
"     1-3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The management and sequelae of childhood sexual abuse will be reviewed here. The epidemiology, evaluation, and differential diagnosis of childhood sexual abuse are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/27/35258?source=see_link\">",
"     \"Evaluation of sexual abuse in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of sexual abuse involves prevention of sexually transmitted infections (STI) and pregnancy. Psychosocial support and anticipatory guidance should be offered to the victims and their non-offending caregivers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     STI prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The need for STI prophylaxis depends upon whether the patient is pre- or postpubertal:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Prepubertal &ndash; STI prophylaxis is not routinely recommended for prepubertal victims because the incidence of infections is low after sexual assault in this patient population, prepubertal girls have a lower risk of ascending infections, and follow-up is typically assured [",
"      <a class=\"abstract\" href=\"UTD.htm?11/15/11510/abstract/4\">",
"       4",
"      </a>",
"      ]. Excessive concern by the caregiver or child concerning STI may make prophylactic treatment appropriate. However, cultures must be obtained prior to treatment whenever prophylaxis is prescribed. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/27/35258?source=see_link&amp;anchor=H16#H16\">",
"       \"Evaluation of sexual abuse in children and adolescents\", section on 'STI testing'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Postpubertal &ndash; For adolescents, STI prophylaxis is recommended for those who present within 72 hours of the event (because of the high prevalence of preexisting asymptomatic infection, the risk of pelvic inflammatory disease, and the possibility of loss to follow-up) [",
"      <a class=\"abstract\" href=\"UTD.htm?11/15/11510/abstract/5\">",
"       5",
"      </a>",
"      ]. For pubertal females who present after 72 hours, STI prophylaxis should be prescribed if the assailant is known to be infected, the victim has signs or symptoms of infection, or at the victim's request [",
"      <a class=\"abstract\" href=\"UTD.htm?11/15/11510/abstract/6,7\">",
"       6,7",
"      </a>",
"      ]. Testing for STI prior to prophylaxis for adolescents is controversial, since identification of a STI is unlikely to provide useful evidence and prophylactic treatment is typically prescribed regardless of culture results [",
"      <a class=\"abstract\" href=\"UTD.htm?11/15/11510/abstract/5,7\">",
"       5,7",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/27/35258?source=see_link&amp;anchor=H16#H16\">",
"       \"Evaluation of sexual abuse in children and adolescents\", section on 'STI testing'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/7/20601?source=see_link&amp;anchor=H8#H8\">",
"       \"Evaluation and management of adult sexual assault victims\", section on 'Laboratory testing'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Almost no clinical trials of STD-related pharmaceuticals include participants younger than 16 years of age, and relatively few include 16- to 17-year-olds. Most data regarding safety and efficacy are extrapolated from late adolescents and young adults. Guidelines for the treatment of specific STD are regularly updated by the CDC and are available on its Web site,",
"    <a class=\"external\" href=\"file://www.cdc.gov/std/treatment/2010/sexual-assault.htm\">",
"     www.cdc.gov/std/treatment/2010/sexual-assault.htm",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11510/abstract/7\">",
"     7",
"    </a>",
"    ]. (See individual topic reviews on sexually transmitted infections.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     HIV prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Definitive data concerning the risk of acquiring the human immunodeficiency virus (HIV) for sexually abused children and adolescents is lacking, although there have been reports of HIV transmission after rape in adults and from sexual abuse in children [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11510/abstract/8-10\">",
"     8-10",
"    </a>",
"    ]. The risk of transmission of the virus may be greater in girls than in adult women because vaginal epithelium in children is thin and adolescents have more cervical ectopy than adults [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11510/abstract/11\">",
"     11",
"    </a>",
"    ]. In addition, children may have been exposed to the same perpetrator repeatedly over time.",
"   </p>",
"   <p>",
"    Recommendations for HIV prophylaxis are generalized from the model for occupational HIV exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11510/abstract/7\">",
"     7",
"    </a>",
"    ]. For adult rape victims, antiretroviral prophylaxis is generally recommended if it can be initiated within 72 hours of exposure, and ideally within four hours. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/7/20601?source=see_link&amp;anchor=H13#H13\">",
"     \"Evaluation and management of adult sexual assault victims\", section on 'HIV infection'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For children and adolescents, decisions regarding HIV prophylaxis are usually made on a case by case basis, taking into consideration the following factors [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11510/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The likelihood that the perpetrator is HIV-positive",
"     </li>",
"     <li>",
"      The nature of the sexual contact and its estimated risk for HIV transmission (eg, whether it involved transfer of secretions, injury, or multiple perpetrators)",
"     </li>",
"     <li>",
"      The time elapsed since the first contact",
"     </li>",
"     <li>",
"      Whether the victim has other ongoing risk factors for HIV infection",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Non-adherence to HIV prophylaxis among sexual assault survivors appears to be prevalent. In several retrospective studies describing HIV prophylaxis for pediatric and adult sexual assault victims, between 13 and 24 percent of patients completed the full 28 day prophylaxis regimen [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11510/abstract/14-16\">",
"     14-16",
"    </a>",
"    ]. Non-adherence to the prophylaxis regimen may limit its effectiveness, as well as increase the likelihood that the patient will develop viral resistance. Consequently, the decision to initiate antiretroviral therapy must include counseling for the victim and family and close follow-up. Consultation with a specialist in treating HIV-infected children is advised [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11510/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Pregnancy prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The overall risk of pregnancy resulting from a sexual assault is 5 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11510/abstract/17\">",
"     17",
"    </a>",
"    ]. The highest risk of pregnancy occurs during the three days preceding and including ovulation (",
"    <a class=\"graphic graphic_table graphicRef58851 \" href=\"UTD.htm?0/33/539\">",
"     table 1",
"    </a>",
"    ). Knowing the timing of the event in relation to the patient's ovulatory period is helpful in further assessing risk. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/2/27685?source=see_link\">",
"     \"Physiology of the normal menstrual cycle\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/6/26724?source=see_link\">",
"     \"Evaluation of the menstrual cycle and timing of ovulation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Emergency contraception should be offered to all pubertal female patients and should be strongly advised to females at highest risk for pregnancy. Emergency contraceptive preparations and administration are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/5/31833?source=see_link\">",
"     \"Emergency contraception\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Hospitalization",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of children who are evaluated for sexual abuse can be discharged with close outpatient follow-up. Indications for hospitalization in child or adolescent victims of sexual abuse include severe injury requiring treatment or when the home environment is unsafe and there are no alternatives for placement.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Psychosocial support",
"    </span>",
"    &nbsp;&mdash;&nbsp;The child's physical and emotional well-being are of primary concern [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11510/abstract/18\">",
"     18",
"    </a>",
"    ]. The child should be reassured that what happened was not the child's fault and that he or she did nothing wrong. Children in whom sexual abuse is confirmed or suspected should be referred to a mental health professional for evaluation and counseling. The family of the victim may also need treatment and support to cope with the emotional trauma of their child's abuse [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11510/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For children who develop psychological sequelae as the result of sexual abuse, cognitive behavioral therapy (CBT), as part of a broader psychosocial intervention, may be helpful. In a systematic review that described 10 randomized trials, CBT appeared to have a positive, though not statistically significant, impact on immediate and longer-term sequelae among children who had been sexually abused [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11510/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Anticipatory guidance",
"    </span>",
"    &nbsp;&mdash;&nbsp;For children whose examination is normal, the patient and family should be informed that the absence of physical findings does not exclude abuse. For patients with abnormal physical findings, the differential diagnosis must be discussed with the family. The child and family should be reassured that injuries typically heal rapidly [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11510/abstract/20\">",
"     20",
"    </a>",
"    ]. The potential risks of STIs (including HIV), as well as decisions to perform cultures or provide prophylactic therapy, should be discussed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/27/35258?source=see_link&amp;anchor=H16#H16\">",
"     \"Evaluation of sexual abuse in children and adolescents\", section on 'STI testing'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H3\">",
"     'STI prophylaxis'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H4\">",
"     'HIV prophylaxis'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The anticipated involvement and intervention of child protective services (CPS) and possible law enforcement should be discussed with the child and parents. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/5/35927?source=see_link\">",
"     \"Child abuse: Social and medicolegal issues\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Additional concerns that the patient",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    family may have about the effects of the abuse (eg, that it has caused the child to lose his or her virginity or may alter the sexual orientation of the child) should be discussed. Listening to family concerns and providing reassurance are often the most important aspects of the evaluation [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11510/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Mandated reporting",
"    </span>",
"    &nbsp;&mdash;&nbsp;Physicians in all 50 states are required to report all cases of suspected or known child sexual abuse [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11510/abstract/1,18\">",
"     1,18",
"    </a>",
"    ]. The designated agency to which sexual abuse should be reported varies by state; physicians should be aware of the local laws. In most jurisdictions, sexual abuse is a criminal offense and must be reported to the police department. If it occurred during a time of inadequate parental supervision, or if the alleged assailant is a family member, it may also need to be reported to CPS [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11510/abstract/21\">",
"     21",
"    </a>",
"    ]. The procedure for reporting is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/5/35927?source=see_link\">",
"     \"Child abuse: Social and medicolegal issues\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     SEQUELAE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Short-term sequelae (ie, those occurring within two years of the assault) of sexual abuse include fear, disturbances in sleep and eating, phobias, guilt, shame, anger, depression, school problems, delinquency, aggression, hostility, antisocial behavior, inappropriate sexual behavior, and running away [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11510/abstract/18,22-24\">",
"     18,22-24",
"    </a>",
"    ]. These sequelae may be the presenting manifestations. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/27/35258?source=see_link&amp;anchor=H4#H4\">",
"     \"Evaluation of sexual abuse in children and adolescents\", section on 'Presentation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Longer-term effects include depression, sleep problems, eating disorders, obesity, feelings of isolation, stigmatization, poor self-esteem, problems with interpersonal relationships, negative effect on sexual function, revictimization, substance abuse, suicidal behavior, and psychosis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11510/abstract/18,24-29\">",
"     18,24-29",
"    </a>",
"    ]. Studies that describe factors that may influence long-term effects include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a systematic review of the impact of sexual abuse on children, the severity of symptoms was affected by penetration, the duration and frequency of the abuse, force, the relationship of the perpetrator to the child, and maternal support [",
"      <a class=\"abstract\" href=\"UTD.htm?11/15/11510/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a cross-sectional survey describing adolescents with histories of sexual abuse, favorable social factors (family connectedness, teacher caring, other adult caring, and school safety) were significantly protective for suicide risk [",
"      <a class=\"abstract\" href=\"UTD.htm?11/15/11510/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     RESOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some communities have a child advocacy center that provides expertise in the evaluation and treatment of sexual abuse victims and the prosecution of sexual abuse perpetrators. These centers may provide social services, law enforcement agencies, legal services, and medical evaluation and may be a resource for consultation. Local advocacy centers can be identified on the National Children's Alliance website (",
"    <a class=\"external\" href=\"file://www.nca-online.org/\">",
"     www.nca-online.org",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Additional resources that may be helpful in the evaluation and management of suspected child abuse are listed (",
"    <a class=\"graphic graphic_table graphicRef57326 graphicRef69110 \" href=\"UTD.htm?12/7/12414\">",
"     table 2A-B",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of all children who have been sexually abused must include attention to the immediate medical and social needs of patients and families, as well as to the local requirements for mandated reporting. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Management'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      With regard to prophylactic treatments, we offer the following recommendations (see",
"      <a class=\"local\" href=\"#H3\">",
"       'STI prophylaxis'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      We suggest that prepubertal children who have no symptoms of sexually transmitted infection (STI)",
"      <strong>",
"       not",
"      </strong>",
"      receive antibiotic prophylaxis (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Children who are prescribed prophylaxis should have specimens sent for culture prior to treatment. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/27/35258?source=see_link&amp;anchor=H16#H16\">",
"       \"Evaluation of sexual abuse in children and adolescents\", section on 'STI testing'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      We suggest that adolescents who have been sexually abused receive antibiotic prophylaxis for STIs (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). The decision to obtain cultures prior to the initiation of treatment should be made on a case by case basis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/7/20601?source=see_link&amp;anchor=H8#H8\">",
"       \"Evaluation and management of adult sexual assault victims\", section on 'Laboratory testing'",
"      </a>",
"      .).",
"     </li>",
"     <li>",
"      Clinicians considering prescribing HIV prophylaxis for children who have been sexually abused should consult with a specialist in treating HIV-infected children. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'HIV prophylaxis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Guidelines for the treatment of specific STIs are regularly updated by the CDC and are available on its Web site",
"      <span class=\"nowrap\">",
"       (www.cdc.gov/std).",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Children who have been sexually abused may experience psychological and behavioral sequelae. They and their families should be offered a referral to a mental health professional. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Sequelae'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11510/abstract/1\">",
"      Kellogg N, American Academy of Pediatrics Committee on Child Abuse and Neglect. The evaluation of sexual abuse in children. Pediatrics 2005; 116:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11510/abstract/2\">",
"      Kempe CH. Sexual abuse, another hidden pediatric problem: the 1977 C. Anderson Aldrich lecture. Pediatrics 1978; 62:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11510/abstract/3\">",
"      Practice parameters for the forensic evaluation of children and adolescents who may have been physically or sexually abused. AACAP Official Action. American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry 1997; 36:423.",
"     </a>",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2010. file://www.cdc.gov/std/treatment/2010/sexual-assault.htm (Accessed on July 30, 2012).",
"    </li>",
"    <li>",
"     American Academy of Pediatrics. Sexually transmitted diseases in adolescents and children. In: Red Book 2006: The Report of the Committee on Infectious Diseases, 27th, Pickering LK.  (Ed), American Academy of Pediatrics, Elk Grove 2006. p.166.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11510/abstract/6\">",
"      Hampton HL. Care of the woman who has been raped. N Engl J Med 1995; 332:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11510/abstract/7\">",
"      Workowski KA, Berman S, Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010; 59:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11510/abstract/8\">",
"      Smith DK, Grohskopf LA, Black RJ, et al. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services. MMWR Recomm Rep 2005; 54:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11510/abstract/9\">",
"      Lindegren ML, Hanson IC, Hammett TA, et al. Sexual abuse of children: intersection with the HIV epidemic. Pediatrics 1998; 102:E46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11510/abstract/10\">",
"      Menick DM, Ngoh F. [Seroprevalence of HIV infection in sexually abused children in Cameroon]. Med Trop (Mars) 2003; 63:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11510/abstract/11\">",
"      Havens PL, American Academy of Pediatrics Committee on Pediatric AIDS. Postexposure prophylaxis in children and adolescents for nonoccupational exposure to human immunodeficiency virus. Pediatrics 2003; 111:1475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11510/abstract/12\">",
"      Atabaki S, Paradise JE. The medical evaluation of the sexually abused child: lessons from a decade of research. Pediatrics 1999; 104:178.",
"     </a>",
"    </li>",
"    <li>",
"     American Academy of Pediatrics. Human immunodeficiency virus infection. In: Red Book 2006: The Report of the Committee on Infectious Diseases, 27th, Pickering LK.  (Ed), American Aademy of Pediatrics, Elk Grove Village 2006. p.394.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11510/abstract/14\">",
"      Olshen E, Hsu K, Woods ER, et al. Use of human immunodeficiency virus postexposure prophylaxis in adolescent sexual assault victims. Arch Pediatr Adolesc Med 2006; 160:674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11510/abstract/15\">",
"      Linden JA, Oldeg P, Mehta SD, et al. HIV postexposure prophylaxis in sexual assault: current practice and patient adherence to treatment recommendations in a large urban teaching hospital. Acad Emerg Med 2005; 12:640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11510/abstract/16\">",
"      Schremmer RD, Swanson D, Kraly K. Human immunodeficiency virus postexposure prophylaxis in child and adolescent victims of sexual assault. Pediatr Emerg Care 2005; 21:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11510/abstract/17\">",
"      Poirier MP. Care of the female adolescent rape victim. Pediatr Emerg Care 2002; 18:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11510/abstract/18\">",
"      Hymel KP, Jenny C. Child sexual abuse. Pediatr Rev 1996; 17:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11510/abstract/19\">",
"      Macdonald G, Higgins JP, Ramchandani P, et al. Cognitive-behavioural interventions for children who have been sexually abused. Cochrane Database Syst Rev 2012; 5:CD001930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11510/abstract/20\">",
"      Adams JA. Medical evaluation of suspected child sexual abuse. J Pediatr Adolesc Gynecol 2004; 17:191.",
"     </a>",
"    </li>",
"    <li>",
"     Ludwig S. Child abuse. In: Textbook of Pediatri Emergency Medicine, 5th, Fleisher GR, Ludwig S, Henretig FM.  (Eds), Lippincott Willims &amp; Wilkins, Philadelphia 2006. p.1761.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11510/abstract/22\">",
"      Beitchman JH, Zucker KJ, Hood JE, et al. A review of the short-term effects of child sexual abuse. Child Abuse Negl 1991; 15:537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11510/abstract/23\">",
"      Kendall-Tackett KA, Williams LM, Finkelhor D. Impact of sexual abuse on children: a review and synthesis of recent empirical studies. Psychol Bull 1993; 113:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11510/abstract/24\">",
"      Johnson CF. Child sexual abuse. Lancet 2004; 364:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11510/abstract/25\">",
"      Ompad DC, Ikeda RM, Shah N, et al. Childhood sexual abuse and age at initiation of injection drug use. Am J Public Health 2005; 95:703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11510/abstract/26\">",
"      Noll JG, Trickett PK, Susman EJ, Putnam FW. Sleep disturbances and childhood sexual abuse. J Pediatr Psychol 2006; 31:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11510/abstract/27\">",
"      Noll JG, Zeller MH, Trickett PK, Putnam FW. Obesity risk for female victims of childhood sexual abuse: a prospective study. Pediatrics 2007; 120:e61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11510/abstract/28\">",
"      Eisenberg ME, Ackard DM, Resnick MD. Protective factors and suicide risk in adolescents with a history of sexual abuse. J Pediatr 2007; 151:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11510/abstract/29\">",
"      Cutajar MC, Mullen PE, Ogloff JR, et al. Schizophrenia and other psychotic disorders in a cohort of sexually abused children. Arch Gen Psychiatry 2010; 67:1114.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6607 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.247-458F631DC3-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_15_11510=[""].join("\n");
var outline_f11_15_11510=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      STI prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      HIV prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Pregnancy prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Hospitalization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Psychosocial support",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Anticipatory guidance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Mandated reporting",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      SEQUELAE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      RESOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6607\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6607|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/33/539\" title=\"table 1\">",
"      Probability of pregnancy after unprotected intercourse",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?4/20/4429\" title=\"table 2A\">",
"      Child abuse neglect resources A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/25/1437\" title=\"table 2B\">",
"      Child abuse neglect resources B",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/5/35927?source=related_link\">",
"      Child abuse: Social and medicolegal issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/5/31833?source=related_link\">",
"      Emergency contraception",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/7/20601?source=related_link\">",
"      Evaluation and management of adult sexual assault victims",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/27/35258?source=related_link\">",
"      Evaluation of sexual abuse in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/6/26724?source=related_link\">",
"      Evaluation of the menstrual cycle and timing of ovulation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/2/27685?source=related_link\">",
"      Physiology of the normal menstrual cycle",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_15_11511="Treatment of scleritis";
var content_f11_15_11511=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment of scleritis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/15/11511/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/15/11511/contributors\">",
"     John H Stone, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/15/11511/contributors\">",
"     Reza Dana, MD, MPH, MSc",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/15/11511/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/15/11511/contributors\">",
"     Jonathan Trobe, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/15/11511/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/15/11511/contributors\">",
"     Paul L Romain, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/15/11511/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 15, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Scleritis is a painful, destructive, and potentially blinding disorder that may also involve the cornea, adjacent episclera, and underlying uveal tract. Up to 50 percent of patients with scleritis have an underlying systemic illness, most often a rheumatic disease.",
"   </p>",
"   <p>",
"    This topic will review the treatment of scleritis. The clinical manifestations and diagnosis of scleritis are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/32/22023?source=see_link\">",
"     \"Clinical manifestations and diagnosis of scleritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of scleritis always requires systemic therapy with NSAIDs, glucocorticoids, or other immunosuppressive drugs. In one study, 67 percent of patients required either high-dose glucocorticoids or the combination of high-dose glucocorticoids and another immunosuppressive agent to control the disease [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11511/abstract/1\">",
"     1",
"    </a>",
"    ]. In some patients, particularly those with peripheral ulcerative keratitis or scleromalacia perforans, surgical intervention is required to preserve vision or prevent globe rupture.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     General principles",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment must be individualized according to the severity of the patient's disease. As an example, patients with either necrotizing anterior scleritis or posterior scleritis require more intensive therapy than those who present with non-necrotizing disease of the anterior [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11511/abstract/2\">",
"     2",
"    </a>",
"    ]. The presence of a systemic inflammatory illness may also dictate an intensive course of therapy, even if the particular subtype of scleritis would normally call for a more benign treatment approach. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/32/22023?source=see_link&amp;anchor=H3#H3\">",
"     \"Clinical manifestations and diagnosis of scleritis\", section on 'Scleritis subtypes'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is absolutely essential that scleritis be managed by an ophthalmologist expert in the care of these patients and by a rheumatologist experienced in employing and managing the immunosuppressive therapies required to treat ocular inflammation.",
"   </p>",
"   <p>",
"    In the absence of systemic disease features that dictate the overall approach to therapy, two major principles guide the treatment of scleritis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The diffuse and nodular subtypes of anterior scleritis (",
"      <a class=\"graphic graphic_picture graphicRef55397 \" href=\"UTD.htm?17/46/18159\">",
"       picture 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef55940 \" href=\"UTD.htm?1/58/1967\">",
"       picture 2",
"      </a>",
"      ) have a reasonable likelihood of responding to NSAIDs alone. If the clinician's sense is that a more aggressive approach is required from the outset or if NSAIDs fail to control the scleral inflammation, most of these patients respond to high-dose",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      . (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Glucocorticoids'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Necrotizing anterior scleritis or posterior scleritis (",
"      <a class=\"graphic graphic_picture graphicRef81029 \" href=\"UTD.htm?2/6/2159\">",
"       picture 3",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef65671 \" href=\"UTD.htm?42/8/43150\">",
"       picture 4",
"      </a>",
"      ) are more likely to be associated with permanent ocular complications and should be treated aggressively. Most cases in recent decades have been treated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      as well as high-dose glucocorticoids, but concern about the adverse effects of cyclophosphamide and the success of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"       rituximab",
"      </a>",
"      -based regimens in treating systemic conditions often accompanied by scleritis (eg, rheumatoid arthritis and granulomatosis with polyangiitis [Wegener&rsquo;s]) have made rituximab plus glucocorticoids often the initial treatment of choice.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Nonsteroidal antiinflammatory drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;NSAID therapy is primarily recommended for patients with the diffuse and nodular subtypes of anterior scleritis (",
"    <a class=\"graphic graphic_picture graphicRef55397 \" href=\"UTD.htm?17/46/18159\">",
"     picture 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef55940 \" href=\"UTD.htm?1/58/1967\">",
"     picture 2",
"    </a>",
"    ). There are few data on which to base the choice of a specific NSAID for the treatment of scleritis. Investigators in Europe have used",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/42/33440?source=see_link\">",
"     flurbiprofen",
"    </a>",
"    for this purpose [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11511/abstract/3\">",
"     3",
"    </a>",
"    ]. The clinical impression of some investigators is that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     indomethacin",
"    </a>",
"    may be more effective than other available NSAIDs [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11511/abstract/1\">",
"     1",
"    </a>",
"    ]. We suggest indomethacin (25 to 75 mg PO three times daily).",
"   </p>",
"   <p>",
"    NSAID treatment should be continued for as long as there is evidence of scleral inflammation. Side effects of NSAIDs and treatment failures may limit the duration of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"     indomethacin",
"    </a>",
"    use. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/49/17177?source=see_link\">",
"     \"Nonselective NSAIDs: Overview of adverse effects\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Glucocorticoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with the diffuse and nodular subtypes of anterior scleritis who fail initial NSAID therapy and those with necrotizing anterior scleritis or posterior scleritis (",
"    <a class=\"graphic graphic_picture graphicRef81029 \" href=\"UTD.htm?2/6/2159\">",
"     picture 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef65671 \" href=\"UTD.htm?42/8/43150\">",
"     picture 4",
"    </a>",
"    ) should be treated with glucocorticoids.",
"   </p>",
"   <p>",
"    Based upon clinical experience, we suggest initial therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    (1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day, up to a maximum daily dose of 80 mg). This regimen is continued for the first four to six weeks of therapy with ongoing assessment of the clinical response. The initial prednisone dose should not be continued beyond six weeks (and usually only four weeks) because of the potential for glucocorticoid-related morbidity. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/47/27386?source=see_link\">",
"     \"Major side effects of systemic glucocorticoids\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If patients have not demonstrated signs of clinical improvement within four to six weeks, an additional immunosuppressive agent must be considered. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Immunosuppressive medications'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Tapering regimen",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no standard tapering regimen for scleritis, but regimens similar to the one outlined below are often used. Assuming that a patient begins",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    at 60",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    and remains on this dose for four weeks, the following taper will require a total of 24 weeks to reach a daily dose of 5 mg:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      dose is tapered by 10 mg each week until a dose of 40",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      is reached.",
"     </li>",
"     <li>",
"      After one week on 40",
"      <span class=\"nowrap\">",
"       mg/day,",
"      </span>",
"      the",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      dose is tapered by 5 mg each week until the dose reaches 20",
"      <span class=\"nowrap\">",
"       mg/day.",
"      </span>",
"     </li>",
"     <li>",
"      After one week on 20",
"      <span class=\"nowrap\">",
"       mg/day,",
"      </span>",
"      the",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      dose is tapered by 2.5 mg each week until the dose reaches 10",
"      <span class=\"nowrap\">",
"       mg/day.",
"      </span>",
"     </li>",
"     <li>",
"      After one week on 10",
"      <span class=\"nowrap\">",
"       mg/day,",
"      </span>",
"      the",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      dose is tapered by 1 mg every two weeks until the dose reaches 5",
"      <span class=\"nowrap\">",
"       mg/day.",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The patient should be monitored carefully during the tapering period, watching for signs of recurrent scleritis or the development of inflammatory disease in other organ systems. Sometimes what appears at presentation to be idiopathic scleritis turns out to be the harbinger of a multiorgan system disease.",
"   </p>",
"   <p>",
"    Continuation of the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    taper can be considered if the patient has achieved and maintained good disease control. Tapering off prednisone completely should not proceed faster than 1",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    decreases every two weeks. Deviations from this regimen are often necessary if patients develop glucocorticoid myopathy or experience disease flares. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/40/23173?source=see_link\">",
"     \"Glucocorticoid-induced myopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Pulse glucocorticoid therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with severe necrotizing anterior scleritis or posterior scleritis that threatens immediate ocular complications, pulse glucocorticoid therapy may be indicated. No controlled clinical trials of this approach have been performed, but, in extrapolation from other clinical experience in the treatment of severe, organ-threatening inflammation, we suggest",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/25/31129?source=see_link\">",
"     methylprednisolone",
"    </a>",
"    1000",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    intravenously for three days. Following the completion of the glucocorticoid pulse, treatment with daily",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    as outlined above may begin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Immunosuppressive medications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immunosuppressive therapy in addition to glucocorticoids is generally given if:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      there is persistent inflammation after two to three weeks of treatment",
"     </li>",
"     <li>",
"      there is progression of disease to a more severe variant (eg, the evolution of diffuse anterior scleritis into the necrotizing subtype)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are no randomized trials in scleritis on which to base the choice of the specific immunosuppressive medication. However, because of the proven effectiveness of both",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"     rituximab",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    in patients with granulomatosis with polyangiitis (Wegener&rsquo;s), the first-line immunosuppressive medication in the treatment of scleritis is typically one of these agents. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/32/34314?source=see_link\">",
"     \"Initial immunosuppressive therapy in granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Options other than",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"     rituximab",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    for patients with milder disease in need of a steroid-sparing agent include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/29/4569?source=see_link\">",
"     mycophenolate",
"    </a>",
"    mofetil, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    . Mycophenolate mofetil has primarily been studied as a steroid-sparing agent, with variable efficacy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11511/abstract/4,5\">",
"     4,5",
"    </a>",
"    ], and may also be used as maintenance therapy; methotrexate has been used in a similar fashion [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11511/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5960341\">",
"    <span class=\"h3\">",
"     Rituximab",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"     rituximab",
"    </a>",
"    regimens are effective in the treatment of rheumatic conditions. Either of these rituximab regimens is an acceptable first-line approach for the treatment of patients with scleritis refractory to glucocorticoids alone. The administration of 1 gram of rituximab twice (with the two doses separated by approximately 15 days) is the regimen approved by the US FDA for the treatment of rheumatoid arthritis. In addition, the use of four 375",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    doses administered one week apart have been approved by the FDA for the treatment of ANCA-associated vasculitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/15/3321?source=see_link&amp;anchor=H13942280#H13942280\">",
"     \"Treatment of cyclophosphamide-resistant granulomatosis with polyangiitis (Wegener&rsquo;s) and microscopic polyangiitis\", section on 'Rituximab'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Cyclophosphamide",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with disease refractory to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"     rituximab",
"    </a>",
"    , we suggest",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    (2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day, with dose adjustments for patients with decreased renal function). We suggest initiating oral cyclophosphamide therapy at a dose of 2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day, with dose adjustments for patients with decreased renal function [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11511/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    With the use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    , the general approach is to establish disease control as quickly as possible through combination therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    and then to discontinue cyclophosphamide after three to six months. Cyclophosphamide is replaced by a medication with a lower risk of toxicity, usually",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Cyclosporine",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     Cyclosporine",
"    </a>",
"    has been used in place of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    in a small case series of patients with severe scleritis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11511/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. The typical dose ranges from 2 to 3",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day in two divided doses.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Maintenance therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because of the toxicity of long-term",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    therapy, a number of less toxic drugs have been used for maintenance therapy after disease control has been attained with cyclophosphamide. The use of some of these drugs (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    ) is based upon their proven value as maintenance therapy in granulomatosis with polyangiitis (Wegener&rsquo;s). Specific data on maintenance therapy in scleritis are extremely limited. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/23/6521?source=see_link\">",
"     \"Maintenance immunosuppressive therapy in granulomatosis with polyangiitis (Wegener&rsquo;s) and microscopic polyangiitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is not clear that patients treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"     rituximab",
"    </a>",
"    require an agent such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    following rituximab therapy, unlike patients treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"       Azathioprine",
"      </a>",
"      &mdash; Before beginning azathioprine, patients should be screened for thiopurine methyltransferase (TPMT) deficiencies. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/63/10232?source=see_link&amp;anchor=H2#H2\">",
"       \"Pharmacology and side effects of azathioprine when used in rheumatic diseases\", section on 'Pharmacology'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      The initial dose of azathioprine is 50",
"      <span class=\"nowrap\">",
"       mg/day.",
"      </span>",
"      If this dose is tolerated well at one week, the daily dose can be increased over several weeks to the range of 1.5 to 3",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day. Most clinicians do not prescribe more than 200",
"      <span class=\"nowrap\">",
"       mg/day,",
"      </span>",
"      even for large individuals.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"       Methotrexate",
"      </a>",
"      &mdash; The initial dose is usually 15",
"      <span class=\"nowrap\">",
"       mg/week,",
"      </span>",
"      with increases in dose every week of 5",
"      <span class=\"nowrap\">",
"       mg/week",
"      </span>",
"      up to 25",
"      <span class=\"nowrap\">",
"       mg/week.",
"      </span>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/29/4569?source=see_link\">",
"       Mycophenolate",
"      </a>",
"      mofetil &mdash; The typical dose of mycophenolate mofetil 1.0 to 1.5 g PO twice daily.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Duration of therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The regimen for tapering and eventually stopping therapy in patients treated with immunosuppressive drugs plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    is not well-defined since there are no studies that address the optimal duration of treatment in this disorder.",
"   </p>",
"   <p>",
"    We attempt to discontinue all immunosuppressive medications eventually after disease remission has been achieved and a disease-free period of suitable length (eg, 6 to12 months) has elapsed. Most patients and clinicians prefer to discontinue glucocorticoids before stopping the other immunosuppressive medicine. A glucocorticoid tapering regimen is described above. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Tapering regimen'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Attempts to gradually taper the glucocorticoid-sparing agent are reasonable in patients who have achieved remission that is sustained after the cessation of glucocorticoids.",
"   </p>",
"   <p>",
"    Tapering of the immunosuppressive medication should be conducted at monthly intervals after the patient is in clinical remission, with planned cessation of therapy over approximately six months. The patient's clinical status must be closely monitored to permit early detection of disease flares at a time when the severity of the illness does not require the resumption of high-dose glucocorticoids.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Resistant disease",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     TNF inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Case reports and small, uncontrolled case series suggest that the tumor necrosis factor (TNF) alpha inhibitor",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/6/28776?source=see_link\">",
"     infliximab",
"    </a>",
"    may be partially effective in the treatment of scleritis that is resistant to treatment with other agents [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11511/abstract/10-14\">",
"     10-14",
"    </a>",
"    ]. Doses in the range of 3 to 5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    administered every four to eight weeks have been employed for this purpose. Additional investigation of infliximab for this indication is required.",
"   </p>",
"   <p>",
"    The failure of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/31/28151?source=see_link\">",
"     etanercept",
"    </a>",
"    (another TNF alpha inhibitor) as a remission maintenance agent in a randomized trial in granulomatosis with polyangiitis (Wegener&rsquo;s) argues against efficacy in scleritis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11511/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Role of surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical procedures may be necessary for diagnosis, repair of scleral or corneal defects, or prevention of globe perforations (",
"    <a class=\"graphic graphic_picture graphicRef63703 \" href=\"UTD.htm?43/47/44797\">",
"     picture 5",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     COURSE AND PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A response of scleritis to therapy is evidenced initially by resolution of pain, which can be rapid and dramatic. Even for patients with severe disease who require",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    , a disease response should be evident within two weeks of starting therapy.",
"   </p>",
"   <p>",
"    Scleritis has a high potential for causing permanent disease-associated morbidity. Some degree of permanent vision loss occurs in approximately 10 percent of patients with anterior diffuse scleritis, 25 percent with nodular scleritis, and 75 to 85 percent with necrotizing scleritis or posterior scleritis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11511/abstract/1,16\">",
"     1,16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Disease complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Common disease complications of scleritis include:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Corneal changes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Peripheral ulcerative keratitis and the corneal melt syndrome, which involves the breakdown of the stromal matrix, may lead to significant visual loss in the involved eye. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/23/22903?source=see_link&amp;anchor=H7#H7\">",
"     \"Ocular manifestations of rheumatoid arthritis\", section on 'Corneal inflammation and melting'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Glaucoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;The advent of effective treatments for scleritis has reduced the incidence of glaucoma as a complication. Glaucoma is most prevalent in association with posterior and nodular scleritis and occurs least often in diffuse scleritis. Elevated intraocular pressure occurs in approximately 15 percent of patients with posterior scleritis and in 20 percent of those with nodular scleritis. Both inflammation and its treatment with glucocorticoids are significant risk factors for this complication.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Cataracts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cataract formation is related to the severity of the scleritis. It primarily occurs in necrotizing scleritis, affecting approximately 20 percent of these patients. The incidence of cataract is much lower (less than 5 percent) with other subtypes of scleritis. Glucocorticoid therapy may be a contributor to cataract formation. Both inflammation and its treatment with glucocorticoids are significant risk factors for this complication.",
"   </p>",
"   <p>",
"    When necessary, cataract surgery is safe, provided that the scleritis has been in remission for at least several months. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/19/2362?source=see_link&amp;anchor=H21#H21\">",
"     \"Cataract in adults\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Posterior segment complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most posterior segment complications represent the effects of posterior scleral inflammation on ocular structures adjacent to the sclera such as the retina and optic nerve. The most serious complication is exudative retinal detachment that involves the macula, thereby resulting in variable but permanent vision loss.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The patient with active scleritis is at significant risk for losing sight. Additionally, scleritis may be a sign of ongoing active inflammation at non-ocular sites and a sign that the underlying disease process needs more aggressive management. The treatment of scleritis varies according to disease subtype. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Treatment'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3\">",
"       'General principles'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Ocular comorbidities are common with scleritis, as are systemic side effects from the treatments. A team approach involving the rheumatologist and the ophthalmologist is often required for optimal management of these patients. Up to 50 percent of patients with scleritis have an underlying systemic illness, usually a rheumatic disease. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/32/22023?source=see_link&amp;anchor=H9#H9\">",
"       \"Clinical manifestations and diagnosis of scleritis\", section on 'Systemic disease associations'",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H2\">",
"       'Treatment'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3\">",
"       'General principles'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest NSAIDs as the initial treatment of choice for diffuse and nodular forms of anterior scleritis (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ), which are less severe forms of the disease. One agent commonly employed in this setting is",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/50/36649?source=see_link\">",
"       indomethacin",
"      </a>",
"      (25 to 75 mg PO three times daily). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Nonsteroidal antiinflammatory drugs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Necrotizing or posterior scleritis are subtypes that are more likely to be associated with permanent ocular complications; thus, we suggest glucocorticoids or the combination of glucocorticoids and another immunosuppressive agent (usually",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"       rituximab",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      ) from the start of therapy in such patients (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      A common starting dose for",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      in this setting is 1",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day, up to a maximum daily dose of 80 mg. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Glucocorticoids'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       Prednisone",
"      </a>",
"      is usually tapered over a period not less than six months, often closer to 9 to 12 months.",
"     </li>",
"     <li>",
"      For patients with severe necrotizing anterior scleritis or posterior scleritis that threatens immediate ocular complications, we suggest",
"      <a class=\"drug drug_general\" href=\"UTD.htm?30/25/31129?source=see_link\">",
"       methylprednisolone",
"      </a>",
"      1000",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"      intravenously for three days (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Pulse glucocorticoid therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with aggressive necrotizing disease, persistent inflammation after two to three weeks of high-dose",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      , or evolution of disease from a mild to severe subtype despite prednisone, we suggest the addition of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"       rituximab",
"      </a>",
"      (1 gram in each of two doses, separated by 15 days). Some patients with particularly aggressive disease may require four rituximab doses (375",
"      <span class=\"nowrap\">",
"       mg/m",
"       <sup>",
"        2",
"       </sup>",
"       ,",
"      </span>",
"      administered weekly).",
"     </li>",
"     <li>",
"      For patients with disease refractory to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"       rituximab",
"      </a>",
"      , we suggest",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      (2",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day, with dose adjustments for patients with decreased renal function) to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Immunosuppressive medications'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      Cyclophosphamide is usually given for a period of three to six months and is then discontinued in favor of a less toxic medication. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Immunosuppressive medications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11511/abstract/1\">",
"      Jabs DA, Mudun A, Dunn JP, Marsh MJ. Episcleritis and scleritis: clinical features and treatment results. Am J Ophthalmol 2000; 130:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11511/abstract/2\">",
"      McCluskey PJ, Watson PG, Lightman S, et al. Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients. Ophthalmology 1999; 106:2380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11511/abstract/3\">",
"      Tuft SJ, Watson PG. Progression of scleral disease. Ophthalmology 1991; 98:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11511/abstract/4\">",
"      Thorne JE, Jabs DA, Qazi FA, et al. Mycophenolate mofetil therapy for inflammatory eye disease. Ophthalmology 2005; 112:1472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11511/abstract/5\">",
"      Sen HN, Suhler EB, Al-Khatib SQ, et al. Mycophenolate mofetil for the treatment of scleritis. Ophthalmology 2003; 110:1750.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11511/abstract/6\">",
"      Jachens AW, Chu DS. Retrospective review of methotrexate therapy in the treatment of chronic, noninfectious, nonnecrotizing scleritis. Am J Ophthalmol 2008; 145:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11511/abstract/7\">",
"      WGET Research Group. Design of the Wegener's Granulomatosis Etanercept Trial (WGET). Control Clin Trials 2002; 23:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11511/abstract/8\">",
"      Hillenkamp J, Kersten A, Althaus C, Sundmacher R. [Cyclosporin A therapy in severe anterior scleritis. 5 severe courses without verification of associated systemic disease treated with cyclosporin A]. Ophthalmologe 2000; 97:863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11511/abstract/9\">",
"      McCarthy JM, Dubord PJ, Chalmers A, et al. Cyclosporine A for the treatment of necrotizing scleritis and corneal melting in patients with rheumatoid arthritis. J Rheumatol 1992; 19:1358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11511/abstract/10\">",
"      Ashok D, Ayliffe WH, Kiely PD. Necrotizing scleritis associated with rheumatoid arthritis: long-term remission with high-dose infliximab therapy. Rheumatology (Oxford) 2005; 44:950.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11511/abstract/11\">",
"      El-Shabrawi Y, Hermann J. Anti-TNF alpha therapy in chronic necrotizing scleritis resistant to standard immunomodulatory therapy in a patient with Wegener's granulomatosis. Eye (Lond) 2005; 19:1017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11511/abstract/12\">",
"      Cazabon S, Over K, Butcher J. The successful use of infliximab in resistant relapsing polychondritis and associated scleritis. Eye (Lond) 2005; 19:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11511/abstract/13\">",
"      Murphy CC, Ayliffe WH, Booth A, et al. Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis. Ophthalmology 2004; 111:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11511/abstract/14\">",
"      Doctor P, Sultan A, Syed S, et al. Infliximab for the treatment of refractory scleritis. Br J Ophthalmol 2010; 94:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11511/abstract/15\">",
"      Wegener's Granulomatosis Etanercept Trial (WGET) Research Group. Etanercept plus standard therapy for Wegener's granulomatosis. N Engl J Med 2005; 352:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11511/abstract/16\">",
"      Pakrou N, Selva D, Leibovitch I. Wegener's granulomatosis: ophthalmic manifestations and management. Semin Arthritis Rheum 2006; 35:284.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5598 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-27.109.116.13-BBD231414A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_15_11511=[""].join("\n");
var outline_f11_15_11511=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      General principles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Nonsteroidal antiinflammatory drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Tapering regimen",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Pulse glucocorticoid therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Immunosuppressive medications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5960341\">",
"      - Rituximab",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Cyclophosphamide",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Cyclosporine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Maintenance therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Duration of therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Resistant disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - TNF inhibitors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Role of surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      COURSE AND PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Disease complications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Corneal changes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Glaucoma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Cataracts",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Posterior segment complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"RHEUM/5598\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/5598|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?17/46/18159\" title=\"picture 1\">",
"      Diffuse anterior scleritis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?1/58/1967\" title=\"picture 2\">",
"      Nodular anterior scleritis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?2/6/2159\" title=\"picture 3\">",
"      Ant scleritis inflammation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/8/43150\" title=\"picture 4\">",
"      Posterior scleritis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?43/47/44797\" title=\"picture 5\">",
"      Tectonic scleral graft",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/19/2362?source=related_link\">",
"      Cataract in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/32/22023?source=related_link\">",
"      Clinical manifestations and diagnosis of scleritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/40/23173?source=related_link\">",
"      Glucocorticoid-induced myopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/32/34314?source=related_link\">",
"      Initial immunosuppressive therapy in granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/23/6521?source=related_link\">",
"      Maintenance immunosuppressive therapy in granulomatosis with polyangiitis (Wegener&rsquo;s) and microscopic polyangiitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/47/27386?source=related_link\">",
"      Major side effects of systemic glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/49/17177?source=related_link\">",
"      Nonselective NSAIDs: Overview of adverse effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/23/22903?source=related_link\">",
"      Ocular manifestations of rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/63/10232?source=related_link\">",
"      Pharmacology and side effects of azathioprine when used in rheumatic diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/15/3321?source=related_link\">",
"      Treatment of cyclophosphamide-resistant granulomatosis with polyangiitis (Wegener&rsquo;s) and microscopic polyangiitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_15_11512="Clinical manifestations, diagnosis, and treatment of plague (Yersinia pestis infection)";
var content_f11_15_11512=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations, diagnosis, and treatment of plague (Yersinia pestis infection)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/15/11512/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/15/11512/contributors\">",
"     Daniel J Sexton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/15/11512/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/15/11512/contributors\">",
"     Stephen B Calderwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/15/11512/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/15/11512/contributors\">",
"     Allyson Bloom, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/15/11512/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 25, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The genus Yersinia includes 11 species, three of which are important human pathogens: Yersinia pestis, Yersinia enterocolitica, and Yersinia pseudotuberculosis. The yersinioses are zoonotic infections of domestic and wild animals; humans are considered incidental hosts that do not contribute to the natural disease cycle.",
"   </p>",
"   <p>",
"    Y. pestis causes plague and is transmitted by fleas. The most common clinical manifestation is acute febrile lymphadenitis, called bubonic plague. Less common forms include septicemia, pneumonia, pharyngeal, and meningeal plague.",
"   </p>",
"   <p>",
"    The clinical features, diagnosis, and treatment of plague will be reviewed here. The epidemiology, microbiology, and pathogenesis of Yersinia pestis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/12/24774?source=see_link\">",
"     \"Epidemiology, microbiology and pathogenesis of plague (Yersinia pestis infection)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Issues related to other Yersinia species are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/21/31062?source=see_link\">",
"     \"Epidemiology of yersiniosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/54/22373?source=see_link\">",
"     \"Microbiology and pathogenesis of Yersinia infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/63/41974?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Yersinia infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/7/32885?source=see_link\">",
"     \"Treatment and prevention of Yersinia enterocolitica and Yersinia pseudotuberculosis infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H525115511\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plague is a murine zoonosis; humans are incidental hosts. Humans acquire plague via bites of rodent fleas, scratches or bites from infected domestic cats, direct handling of infected animal tissues, inhalation of respiratory secretions from infected animals, inhalation of aerosolized droplets from infected humans, consumption of contaminated food, or by laboratory exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/1-5\">",
"     1-5",
"    </a>",
"    ]. The incubation period is generally two to eight days. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/12/24774?source=see_link\">",
"     \"Epidemiology, microbiology and pathogenesis of plague (Yersinia pestis infection)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are three major clinical syndromes associated with plague: bubonic plague, septicemic plague, and pneumonic plague [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/1\">",
"     1",
"    </a>",
"    ]. Bubonic plague accounts for 80 to 95 percent of cases; septicemic plague accounts for 10 to 20 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/1,6\">",
"     1,6",
"    </a>",
"    ]. Pneumonic plague is generally rare [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/7\">",
"     7",
"    </a>",
"    ]. Overall, the estimated mortality is 60 to 100 percent in untreated plague compared with less than 15 percent with treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/8\">",
"     8",
"    </a>",
"    ]. In a series of 23 cases of plague in the United States between 1977 and 1998, 17 were bubonic plague and the mortality rate was 22 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Bubonic plague",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bubonic plague is the most common form of plague; it accounts for 80 to 95 percent of cases. Skin lesions at the site of flea bite are usually ignored or inapparent. However some patients may have eschars, pustules, or even necrotic lesions resembling ecthyma gangrenosum [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/10\">",
"     10",
"    </a>",
"    ]. Bites on the extremities may be associated with lymph nodes swellings in the region draining the inoculation site. A minority of patients develop skin lesions, such as purpura, associated with disseminated intravascular coagulation [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Bubonic plague is characterized by the sudden onset of fever, chills, weakness, and headache, followed by intense pain and swelling in a lymph node bearing area (bubo), which may be preceded by lymphadenopathy. The acute bubo is characterized by exquisite tenderness without fluctuation, often associated with erythema and edema of the overlying skin. The inguinal region is the most frequently involved site (the word \"bubo\" derives from the Greek word for \"groin\"); axillary or cervical regions may also be involved (",
"    <a class=\"graphic graphic_picture graphicRef52633 \" href=\"UTD.htm?14/3/14385\">",
"     picture 1",
"    </a>",
"    ). In bubonic plague associated with cat exposure, axillary, cervical, or epitrochlear buboes may be observed [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the absence of treatment, the initial bubonic stage may be followed by disseminated infection (sepsis) in approximately 50 percent of untreated cases, which can lead to complications, such as pneumonia (secondary pneumonic plague) and meningitis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/12\">",
"     12",
"    </a>",
"    ]. Bacteremic patients may develop signs of septic shock [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Septicemic plague",
"    </span>",
"    &nbsp;&mdash;&nbsp;Septicemic plague, without a preceding bubo, accounts for 10 to 20 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/1\">",
"     1",
"    </a>",
"    ]. The septicemic form of plague may be particularly difficult to diagnose in a timely manner because characteristic clinical clues, such as a bubo, are not present. Patients with septicemic plague are febrile and extremely ill but do not have localizing signs or symptoms. Gastrointestinal symptoms, including nausea, vomiting, diarrhea and abdominal pain, may be observed. Hypotension, disseminated intravascular coagulation, and multiorgan failure develop in the later stages of the illness.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Pneumonic plague",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pneumonic plague can be primary or secondary. Primary pneumonic plague can be acquired by inhalation of respiratory secretions or aerosolized droplets from infected animals or humans, or by laboratory exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/2-4,11,13\">",
"     2-4,11,13",
"    </a>",
"    ]. Secondary pneumonic plague is more common and arises via hematogenous spread of bacteria from a bubo or other source.",
"   </p>",
"   <p>",
"    Primary pneumonic plague has a short incubation period, ranging from a few hours to a few days. Affected patients typically present with the sudden onset of dyspnea, high fever, pleuritic chest pain, and cough that may be accompanied by characteristic bloody sputum. Pneumonic plague is rapidly fatal unless an appropriate antimicrobial agent is begun within the first day of illness [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Secondary pneumonic plague develops in approximately 10 percent of patients with plague in the United States, usually as a result of delayed treatment of bubonic infection. The manifestations are as described above for primary pneumonic plague.",
"   </p>",
"   <p>",
"    Human-to-human transmission of plague via aerosols remains a source of controversy. In one study of an outbreak in Madagascar, 8 percent of 154 contacts became infected with Y. pestis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/7\">",
"     7",
"    </a>",
"    ]. However, in a study of cases of plague from an outbreak in Uganda, transmission was observed only in very close contacts (caregivers) and in the patients last days of life [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/14\">",
"     14",
"    </a>",
"    ]. Treatment of patients and prophylaxis of contacts stopped the outbreak in Madagascar cited above. The capacity for spread via aerosolization makes Y. pestis a potential bioterrorism agent. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Prevention'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/46/22247?source=see_link\">",
"     \"Identifying and managing casualties of biological terrorism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Other manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plague can cause a number of other manifestations. Meningitis can occur from bacteremia in conjunction with any of the three forms of plague, or may occur as a \"primary\" meningeal infection following occult bacteremic seeding. Symptoms tend to be similar to other bacterial meningitides, and cerebrospinal fluid examination typically reveals a low glucose concentration, increased protein concentration, and a neutrophilic pleocytosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/37/23129?source=see_link\">",
"     \"Clinical features and diagnosis of acute bacterial meningitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other manifestations of plague include pharyngitis and tonsillitis associated with anterior cervical lymphadenitis, following ingestion of Y. pestis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/3,11\">",
"     3,11",
"    </a>",
"    ]. One small series described involvement of the urinary tract or gastrointestinal tract in 14 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/3\">",
"     3",
"    </a>",
"    ]. Asymptomatic transient pharyngeal carriage of Y. pestis has been described in healthy contacts of bubonic plague cases. One small series described involvement of the urinary tract or gastrointestinal tract in 14 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/3\">",
"     3",
"    </a>",
"    ]. Asymptomatic transient pharyngeal carriage of Y. pestis has been described in healthy contacts of bubonic plague cases [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients who develop plague without a bubo are often difficult to recognize particularly when they occur as sporadic cases in the absence of a recognized outbreak. Such patients may develop manifestations of multiple organ dysfunction and die prior to or in spite of a recognized antemortem diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2491475\">",
"    <span class=\"h2\">",
"     Routine clinical studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine laboratory and radiographic studies do not provide findings specific for plague. White blood cell counts may vary from 3000 to",
"    <span class=\"nowrap\">",
"     100,000/microL,",
"    </span>",
"    but white cell counts",
"    <span class=\"nowrap\">",
"     &gt;20,000/microL",
"    </span>",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    thrombocytopenia are present in approximately one-half of all cases. The combination of white cell counts &gt;20,000 and thrombocytopenia has been considered as an indicator of plague in endemic areas [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The sputum may initially be clear, but it is more typically purulent, or hemorrhagic, and it usually contains gram-negative rods when Gram stains are done.",
"   </p>",
"   <p>",
"    The radiographic appearance of pneumonic plague is not sufficiently specific to be diagnostic. Chest radiography may demonstrate bronchopneumonia, consolidation, cavities, or pleural effusions. Unlike other more common bacterial pneumonias, hilar or mediastinal adenopathy are sometimes seen in patients with plague pneumonia, and this finding may provide one clue to the presence of this unusual pathogen [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/17\">",
"     17",
"    </a>",
"    ]. The differential diagnosis of plague pneumonia includes other acute bacterial, fungal, or mycobacterial pneumonias. Hantavirus infections should be included in the differential diagnosis in geographic areas where this virus is known to be endemic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A high index of suspicion must be maintained for the timely diagnosis of plague. Patients with fever and painful lymphadenopathy should be questioned about travel to areas of endemic disease, including the southwestern United States. In addition, animal or rodent vector contact within the preceding 10 days may provide clues that raise suspicion for a diagnosis of plague. The diagnosis of plague is established by isolation of the organism in culture or by serologic testing [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Three important diagnostic clues to the presence of plague include [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/7\">",
"     7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The presence of fever in a person with either known contact with dead rodents or residence or travel to a plague-endemic region.",
"     </li>",
"     <li>",
"      The presence of fever, hypotension, and unexplained regional lymphadenitis.",
"     </li>",
"     <li>",
"      The presence of clinical findings of pneumonia in association with hemoptysis and sputum containing gram-negative rods on Gram&rsquo;s stain.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Culture and staining",
"    </span>",
"    &nbsp;&mdash;&nbsp;Yersinia grows well on common laboratory media. Microbiology personnel should be informed of any specimen suspected to harbor the organism so that they may exercise proper precautions to prevent laboratory acquisition of infection.",
"   </p>",
"   <p>",
"    Blood cultures may be positive in 27 to 96 percent of patients, depending on the form of their clinical presentation [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/4,11\">",
"     4,11",
"    </a>",
"    ]. Y. pestis can also be cultured from sputum, cerebrospinal fluid, or bubo aspirate material. In one study, cultures of bubo aspirates were positive in 10 of 13 cases [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/3\">",
"     3",
"    </a>",
"    ]. Aspiration of the bubo after injection with saline may be necessary to obtain an adequate specimen.",
"   </p>",
"   <p>",
"    Examination of a peripheral blood specimen with Wright-Giemsa stain demonstrates rod-shaped organisms in up to 40 percent of cases. Microscopy evaluation of a bubo aspirate may also demonstrate the organism. Wayson's stain may demonstrate the typical bipolar staining, which resembles a \"closed safety pin\" (",
"    <a class=\"graphic graphic_picture graphicRef81633 \" href=\"UTD.htm?33/15/34037\">",
"     picture 2",
"    </a>",
"    ). Gram stain shows small gram-negative coccobacilli. Fluorescent antibody is also useful if available.",
"   </p>",
"   <p>",
"    Automated bacterial identification systems may not be sufficiently accurate in identifying Y. pestis in a specimen culture, as illustrated by reports of misclassification as Pseudomonas luteola, Acinetobacter lwoffi, and Yersinia pseudotuberculosis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/18\">",
"     18",
"    </a>",
"    ]. Thus, in a patient with symptoms consistent with plague or microbiologic findings of an organism with bipolar staining, the possibility of Y. pestis should not be discounted if these other organisms are detected by such systems.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Serology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serologic confirmation requires acute and convalescent serum, looking for at least a fourfold rise in antibody titers to the F-1 antigen of Y. pestis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/2\">",
"     2",
"    </a>",
"    ]. A single titer of &gt;1:16 using the passive hemagglutination test is suggestive of the diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Rapid tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;A rapid diagnostic test capable of detecting 0.5",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    of the Y. pestis F1 antigen in the sputum or serum within 15 minutes has been developed [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/7,19\">",
"     7,19",
"    </a>",
"    ]. In field testing in Madagascar, the assay had 100 percent sensitivity and specificity for Y. pestis, other Yersinia spp, and other bacteria; positive and negative predictive values were 91 and 87 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Presumptive identification of Y. pestis can be made by polymerase chain reaction (PCR) or antigen-capture enzyme-linked immunosorbent assay [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/20,21\">",
"     20,21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Appropriate and timely therapy can markedly improve patient outcomes, and chemoprophylaxis can prevent spread. Bubonic plague has a mortality rate of 50 to 90 percent if untreated (10 to 20 percent if treated) and pneumonic plague has a mortality rate of 100 percent if untreated (50 percent if treated) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/1,7\">",
"     1,7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Antibiotic regimens",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/9/18583?source=see_link\">",
"     Streptomycin",
"    </a>",
"    was considered the drug of choice for plague based on nonrandomized studies from the 1940s and 1950s [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/22-24\">",
"     22-24",
"    </a>",
"    ] and on treatment of thousands of patients in Vietnam between 1960 and 1975 [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/16,25\">",
"     16,25",
"    </a>",
"    ]. Dosing is 30",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day IM (up to a total dose of 2 g) in two divided doses for 10 days. Careful monitoring is required, as streptomycin is ototoxic and nephrotoxic.",
"   </p>",
"   <p>",
"    As",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/9/18583?source=see_link\">",
"     streptomycin",
"    </a>",
"    is now not widely available in many locations, and as many clinicians are more familiar with the dosing and use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/10/36000?source=see_link\">",
"     gentamicin",
"    </a>",
"    , this drug is an acceptable alternative agent to streptomycin, based on in vitro susceptibility studies, animal models, and anecdotal reports of efficacy in treating humans with plague [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/26-31\">",
"     26-31",
"    </a>",
"    ]. A retrospective analysis of 50 patients suggested that gentamicin is at least as effective as streptomycin [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/31\">",
"     31",
"    </a>",
"    ]. Gentamicin is generally considered safer than streptomycin for use in pregnant women and in children.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"     Doxycycline",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/49/2840?source=see_link\">",
"     tetracycline",
"    </a>",
"    are acceptable alternative agents for patients who cannot tolerate aminoglycosides [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/26-31\">",
"     26-31",
"    </a>",
"    ]. In a randomized trial involving 65 patients with symptoms of bubonic, septicemic, or pneumonic plague who were randomly assigned to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/10/36000?source=see_link\">",
"     gentamicin",
"    </a>",
"    or doxycycline, favorable responses were observed with both therapies (94 percent for gentamicin and 97 percent for doxycycline) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/30\">",
"     30",
"    </a>",
"    ]. Dosing for doxycycline in adults consists of a loading dose on the first day (200 mg orally every 12 hours) followed by 100 mg orally every 12 hours. Dosing for tetracycline in adults consists of a loading dose of 2 g orally, followed by a 2",
"    <span class=\"nowrap\">",
"     g/day",
"    </span>",
"    in four divided doses. The duration of therapy is 7 to 10 days.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33504?source=see_link\">",
"     Levofloxacin",
"    </a>",
"    is an effective agent against plague in animal studies. In a study of African green monkeys exposed to aerosolized Y. pestis, 16 of 17 animals randomized to treatment with levofloxacin survived compared with none of the seven control animals, which all died within five days of exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/32\">",
"     32",
"    </a>",
"    ]. Levofloxacin was administered at a dose equivalent to 500 mg IV every 24 hours in humans for a total of 10 days. Other in vitro and animal data have also suggested efficacy of fluoroquinolones, but clinical data are limited [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. Nevertheless, because the relative rarity of human disease would make clinical trials difficult to perform, the animal study above provided sufficient evidence to prompt the Food and Drug Administration of the United States to add levofloxacin to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/9/18583?source=see_link\">",
"     streptomycin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"     doxycycline",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/49/2840?source=see_link\">",
"     tetracycline",
"    </a>",
"    as acceptable antibiotics for the treatment of plague [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/35\">",
"     35",
"    </a>",
"    ]. We would reserve the use of levofloxacin for patients who cannot tolerate aminoglycosides or tetracyclines.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/54/1897?source=see_link\">",
"     Chloramphenicol",
"    </a>",
"    is an alternative agent that achieves excellent spinal fluid penetration and may be used for treatment of meningitis either alone or in combination with an aminoglycoside [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/36\">",
"     36",
"    </a>",
"    ]. Chloramphenicol is given as a loading dose (25 to 30",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    body weight; maximum 2 g) followed by 50 to 60",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day (maximum 4 g per day) in four divided doses. With clinical improvement, the dosing may be reduced to 25 to 30",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day. The optimal duration of therapy is uncertain. Based on general principles of the treatment for bacterial meningitis, it is reasonable to continue treatment for at least seven days or for at least a few days after clinical signs and symptoms of infection, such as fever, leukocytosis, and mental status changes, have resolved.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     Trimethoprim-sulfamethoxazole",
"    </a>",
"    has been used successfully to treat bubonic plague, but responses may be delayed or incomplete and it is not considered a first line choice [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/37\">",
"     37",
"    </a>",
"    ]. Penicillins, cephalosporins, and macrolides are not appropriate agents for treatment of plague.",
"   </p>",
"   <p>",
"    Drug resistant isolates have been described. In 1995, an isolate from a patient in Madagascar was noted to contain a plasmid that conferred resistance to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"     ampicillin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/54/1897?source=see_link\">",
"     chloramphenicol",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/10/40102?source=see_link\">",
"     kanamycin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/9/18583?source=see_link\">",
"     streptomycin",
"    </a>",
"    , spectinomycin, sulfonamides,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/49/2840?source=see_link\">",
"     tetracycline",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/10/3240?source=see_link\">",
"     minocycline",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/38\">",
"     38",
"    </a>",
"    ]. The isolate remained sensitive to other aminoglycosides, quinolones, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/36/26182?source=see_link\">",
"     trimethoprim",
"    </a>",
"    . The plasmid probably originated among Enterobacteriaceae and was readily passed in vitro between Y. pestis strains. Another isolate has been described with plasmid-mediated high-level streptomycin resistance [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Outbreaks of multidrug resistant plague have not been reported, although surveillance of resistance patterns is needed. Modification of empiric therapy may be required to conform to local susceptibility patterns.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Isolation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients suspected of having any form of plague should be placed on strict droplet precautions until pneumonia has been ruled out, sputum cultures are negative, and at least 48 hours of effective antimicrobial therapy has been administered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reducing exposure is the best preventive measure. In known endemic areas, handling dead rodent carcasses should be avoided. Other preventative measures include rodent control, flea control, and use of insect repellents. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/1/43031?source=see_link\">",
"     \"Prevention of arthropod and insect bites: Repellents and other measures\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Post exposure prophylaxis is warranted for individuals with unprotected face-to-face contact (ie, within one meter) of patients with known or suspected pneumonic plague who have not received at least 48 hours of effective antimicrobial therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/1\">",
"     1",
"    </a>",
"    ]. Prophylaxis for adults consists of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"     doxycycline",
"    </a>",
"    (100 mg orally twice daily for seven days).",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33504?source=see_link\">",
"     Levofloxacin",
"    </a>",
"    (500 mg orally once daily for 10 days) may be an acceptable alternative for those who cannot take doxycycline based on animal data.",
"   </p>",
"   <p>",
"    For prophylaxis of pregnant women or children,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    may be administered for five to seven days, although data confirming efficacy are lacking [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/10\">",
"     10",
"    </a>",
"    ]. Dosing consists of one double-strength tablet twice daily in adults and 4",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    of the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/36/26182?source=see_link\">",
"     trimethoprim",
"    </a>",
"    component twice daily in children.",
"   </p>",
"   <p>",
"    A killed whole cell vaccine has been developed but is no longer commercially available in the United States. Data on the efficacy of the vaccine are limited; much of the experience has been with vaccination of military personnel deployed to areas endemic for plague, such as Vietnam [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/40\">",
"     40",
"    </a>",
"    ]. The vaccination consists of a primary series of two injections one to three months apart, followed by a booster every six months for the duration of exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The concern about plague as a bioterrorism agent has led to the development of a number of newer vaccines, some of which are undergoing clinical testing [",
"    <a class=\"abstract\" href=\"UTD.htm?11/15/11512/abstract/1,41\">",
"     1,41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2492226\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bubonic plague accounts for 80 to 95 percent of plague cases, with a relatively low mortality rate if timely treatment is administered. Bubonic plague is characterized by the sudden onset of fever, chills, weakness, and headache, followed by intense pain and swelling in a lymph node bearing area (bubo), which may be preceded by lymphadenopathy. The acute bubo is characterized by exquisite tenderness without fluctuation, often associated with erythema and edema of the overlying skin (",
"      <a class=\"graphic graphic_picture graphicRef52633 \" href=\"UTD.htm?14/3/14385\">",
"       picture 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Bubonic plague'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Septicemic plague without a preceding bubo accounts for 10 to 20 percent of plague cases. Patients with septicemic plague are febrile and extremely ill but do not have localizing signs or symptoms. Gastrointestinal symptoms, including nausea, vomiting, diarrhea, and abdominal pain, may be observed. Hypotension, disseminated intravascular coagulation, and multiorgan failure develop in the later stages of the illness. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Septicemic plague'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pneumonic plague is generally rare; the mortality rate is 100 percent if untreated (50 percent if treated). Pneumonic plague can be primary (eg, acquired by inhalation of respiratory secretions or aerosolized droplets from infected animals or humans or by laboratory exposure) or secondary (eg, developing in the setting of bubonic or septicemic plague). (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Pneumonic plague'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of plague is established by isolation of the organism in culture, by serologic testing or by rapid testing in appropriate settings. A high index of suspicion must be maintained for the timely diagnosis of plague. Patients with fever and painful lymphadenopathy should be questioned about travel to areas of endemic disease. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest",
"      <a class=\"drug drug_general\" href=\"UTD.htm?18/9/18583?source=see_link\">",
"       streptomycin",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/10/36000?source=see_link\">",
"       gentamicin",
"      </a>",
"      for treatment of plague (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"       Doxycycline",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/49/2840?source=see_link\">",
"       tetracycline",
"      </a>",
"      are acceptable alternative agents for patients who cannot tolerate aminoglycosides.",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33504?source=see_link\">",
"       Levofloxacin",
"      </a>",
"      is a possible option for patients who cannot tolerate aminoglycosides or tetracyclines. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Antibiotic regimens'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients suspected of having any form of plague should be placed on strict droplet precautions until pneumonia has been ruled out, sputum cultures are negative, and at least 48 hours of effective antimicrobial therapy has been administered. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Isolation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Post exposure prophylaxis is warranted for individuals with unprotected face-to-face contact (ie, within 2 meters) of patients with known or suspected pneumonic plague who have not received at least 48 hours of effective antimicrobial therapy. We suggest post exposure prophylaxis with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"       doxycycline",
"      </a>",
"      (100 mg orally twice daily for seven days) (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"       Trimethoprim-sulfamethoxazole",
"      </a>",
"      is an acceptable alternative agent for pregnant women and children. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Prevention'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/1\">",
"      Prentice MB, Rahalison L. Plague. Lancet 2007; 369:1196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/2\">",
"      Centers for Disease Control and Prevention (CDC). Human plague--United States, 1993-1994. MMWR Morb Mortal Wkly Rep 1994; 43:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/3\">",
"      Crook LD, Tempest B. Plague. A clinical review of 27 cases. Arch Intern Med 1992; 152:1253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/4\">",
"      Weniger BG, Warren AJ, Forseth V, et al. Human bubonic plague transmitted by a domestic cat scratch. JAMA 1984; 251:927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/5\">",
"      Centers for Disease Control and Prevention (CDC). Fatal laboratory-acquired infection with an attenuated Yersinia pestis Strain--Chicago, Illinois, 2009. MMWR Morb Mortal Wkly Rep 2011; 60:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/6\">",
"      Daya M, Nakamura Y. Pulmonary disease from biological agents: anthrax, plague, Q fever, and tularemia. Crit Care Clin 2005; 21:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/7\">",
"      Ratsitorahina M, Chanteau S, Rahalison L, et al. Epidemiological and diagnostic aspects of the outbreak of pneumonic plague in Madagascar. Lancet 2000; 355:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/8\">",
"      Campbell GL, Hughes JM. Plague in India: a new warning from an old nemesis. Ann Intern Med 1995; 122:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/9\">",
"      Gage KL, Dennis DT, Orloski KA, et al. Cases of cat-associated human plague in the Western US, 1977-1998. Clin Infect Dis 2000; 30:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/10\">",
"      Welty TK, Grabman J, Kompare E, et al. Nineteen cases of plague in Arizona. A spectrum including ecthyma gangrenosum due to plague and plague in pregnancy. West J Med 1985; 142:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/11\">",
"      Butler T. Yersinia infections: centennial of the discovery of the plague bacillus. Clin Infect Dis 1994; 19:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/12\">",
"      Warren R, Lockman H, Barnewall R, et al. Cynomolgus macaque model for pneumonic plague. Microb Pathog 2011; 50:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/13\">",
"      Wang H, Cui Y, Wang Z, et al. A dog-associated primary pneumonic plague in Qinghai Province, China. Clin Infect Dis 2011; 52:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/14\">",
"      Begier EM, Asiki G, Anywaine Z, et al. Pneumonic plague cluster, Uganda, 2004. Emerg Infect Dis 2006; 12:460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/15\">",
"      Marshall JD Jr, Quy DV, Gibson FL. Asymptomatic pharyngeal plague infection in Vietnam. Am J Trop Med Hyg 1967; 16:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/16\">",
"      Butler T, Bell WR, Arnold K. Yersinia pestis infection in Vietnam. I. Clinical and hematologic aspects. J Infect Dis 1974; 129:Suppl:S78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/17\">",
"      Alsofrom DJ, Mettler FA Jr, Mann JM. Radiographic manifestations of plaque in New Mexico, 1975-1980. A review of 42 proved cases. Radiology 1981; 139:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/18\">",
"      Tourdjman M, Ibraheem M, Brett M, et al. Misidentification of Yersinia pestis by Automated Systems, Resulting in Delayed Diagnoses of Human Plague Infections -- Oregon and New Mexico, 2010-2011. Clin Infect Dis 2012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/19\">",
"      Chanteau S, Rahalison L, Ralafiarisoa L, et al. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet 2003; 361:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/20\">",
"      Lo&iuml;ez C, Herwegh S, Wallet F, et al. Detection of Yersinia pestis in sputum by real-time PCR. J Clin Microbiol 2003; 41:4873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/21\">",
"      Radnedge L, Gamez-Chin S, McCready PM, et al. Identification of nucleotide sequences for the specific and rapid detection of Yersinia pestis. Appl Environ Microbiol 2001; 67:3759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/22\">",
"      Wagle PM. Recent advances in the treatment of bubonic plague. Indian J Med Sci 1948; 2:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/23\">",
"      MEYER KF. Modern therapy of plague. J Am Med Assoc 1950; 144:982.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/24\">",
"      Datt Gupta AK. A short note on plague cases treated at Campbell Hospital. Ind Med Gaz 1948; 83:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/25\">",
"      Butler T, Levin J, Linh NN, et al. Yersinia pestis infection in Vietnam. II. Quantiative blood cultures and detection of endotoxin in the cerebrospinal fluid of patients with meningitis. J Infect Dis 1976; 133:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/26\">",
"      Wong JD, Barash JR, Sandfort RF, Janda JM. Susceptibilities of Yersinia pestis strains to 12 antimicrobial agents. Antimicrob Agents Chemother 2000; 44:1995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/27\">",
"      Bonacorsi SP, Scavizzi MR, Guiyoule A, et al. Assessment of a fluoroquinolone, three beta-lactams, two aminoglycosides, and a cycline in treatment of murine Yersinia pestis infection. Antimicrob Agents Chemother 1994; 38:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/28\">",
"      Frean JA, Arntzen L, Capper T, et al. In vitro activities of 14 antibiotics against 100 human isolates of Yersinia pestis from a southern African plague focus. Antimicrob Agents Chemother 1996; 40:2646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/29\">",
"      Smith MD, Vinh DX, Nguyen TT, et al. In vitro antimicrobial susceptibilities of strains of Yersinia pestis. Antimicrob Agents Chemother 1995; 39:2153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/30\">",
"      Mwengee W, Butler T, Mgema S, et al. Treatment of plague with gentamicin or doxycycline in a randomized clinical trial in Tanzania. Clin Infect Dis 2006; 42:614.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/31\">",
"      Boulanger LL, Ettestad P, Fogarty JD, et al. Gentamicin and tetracyclines for the treatment of human plague: review of 75 cases in new Mexico, 1985-1999. Clin Infect Dis 2004; 38:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/32\">",
"      Layton RC, Mega W, McDonald JD, et al. Levofloxacin cures experimental pneumonic plague in African green monkeys. PLoS Negl Trop Dis 2011; 5:e959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/33\">",
"      Peterson JW, Moen ST, Healy D, et al. Protection Afforded by Fluoroquinolones in Animal Models of Respiratory Infections with Bacillus anthracis, Yersinia pestis, and Francisella tularensis. Open Microbiol J 2010; 4:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/34\">",
"      Kuberski T, Robinson L, Schurgin A. A case of plague successfully treated with ciprofloxacin and sympathetic blockade for treatment of gangrene. Clin Infect Dis 2003; 36:521.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm302220.htm (Accessed on May 01, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/36\">",
"      MCCRUMB FR Jr, MERCIER S, ROBIC J, et al. Chloramphenicol and terramycin in the treatment of pneumonic plague. Am J Med 1953; 14:284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/37\">",
"      . Letter: Co-trimoxazole in bubonic plague. Br Med J 1973; 4:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/38\">",
"      Galimand M, Guiyoule A, Gerbaud G, et al. Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. N Engl J Med 1997; 337:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/39\">",
"      Guiyoule A, Gerbaud G, Buchrieser C, et al. Transferable plasmid-mediated resistance to streptomycin in a clinical isolate of Yersinia pestis. Emerg Infect Dis 2001; 7:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/40\">",
"      Cavanaugh DC, Elisberg BL, Llewellyn CH, et al. Plague immunization. V. Indirect evidence for the efficacy of plague vaccine. J Infect Dis 1974; 129:Suppl:S37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/15/11512/abstract/41\">",
"      Morris SR. Development of a recombinant vaccine against aerosolized plague. Vaccine 2007; 25:3115.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3131 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-219.243.220.100-C38B34FA94-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_15_11512=[""].join("\n");
var outline_f11_15_11512=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H2492226\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H525115511\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Bubonic plague",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Septicemic plague",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Pneumonic plague",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Other manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2491475\">",
"      Routine clinical studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Culture and staining",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Serology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Rapid tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Antibiotic regimens",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Isolation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2492226\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/3131\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3131|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/3/14385\" title=\"picture 1\">",
"      Axillary bubo",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?33/15/34037\" title=\"picture 2\">",
"      Bipolar stain of Yersinia pestis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/37/23129?source=related_link\">",
"      Clinical features and diagnosis of acute bacterial meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/63/41974?source=related_link\">",
"      Clinical manifestations and diagnosis of Yersinia infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/21/31062?source=related_link\">",
"      Epidemiology of yersiniosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/12/24774?source=related_link\">",
"      Epidemiology, microbiology and pathogenesis of plague (Yersinia pestis infection)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/46/22247?source=related_link\">",
"      Identifying and managing casualties of biological terrorism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/54/22373?source=related_link\">",
"      Microbiology and pathogenesis of Yersinia infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/1/43031?source=related_link\">",
"      Prevention of arthropod and insect bites: Repellents and other measures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/7/32885?source=related_link\">",
"      Treatment and prevention of Yersinia enterocolitica and Yersinia pseudotuberculosis infection",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_15_11513="Capillary microthrombi mixed cryo Light";
var content_f11_15_11513=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F50680&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F50680&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Capillary microthrombi in mixed cryoglobulinemia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 257px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light micrograph in mixed cryoglobulinemia showing large cryoprecipitates occluding many of the capillary loops (arrows), called microthrombi.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal glomerulus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 253px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light micrograph of a normal glomerulus. There are only 1 or 2 cells per capillary tuft, the capillary lumens are open, the thickness of the glomerular capillary wall (long arrow) is similar to that of the tubular basement membranes (short arrow), and the mesangial cells and mesangial matrix are located in the central or stalk regions of the tuft (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut G Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_15_11513=[""].join("\n");
var outline_f11_15_11513=null;
var title_f11_15_11514="Exposure of occult upper parathyroid gland";
var content_f11_15_11514=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F79942&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F79942&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 618px\">",
"   <div class=\"ttl\">",
"    Exposure of occult upper parathyroid gland",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 598px; height: 624px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Exposure of occult right upper parathyroid.",
"    <br>",
"     (A) Anteroposterior view of the neck showing the initial route of dissection for mobilization of the upper pole, right thyroid lobe. Dissection is kept on the thyroid's surface to avoid injury to the external branch of the right superior laryngeal nerve.",
"     <br>",
"      (B) Sharp downward and left retraction of the upper pole (arrow) shows the back of the upper pole and zone of recurrent laryngeal nerve insertion into the larynx.",
"      <br>",
"       (C) Sharp left retraction of the upper and lower poles (arrows) rotates the trachea and larynx to expose the posterior esophagus and larynx.",
"       <br>",
"        (D) Retraction (arrows) for inspection of the proximal superior thyroid artery and carotid sheath.",
"        <div class=\"footnotes\">",
"        </div>",
"        <div class=\"reference\">",
"         Reproduced with permission from: Moore, Jr FD. Secondary and tertiary hyperparathyroidism. In: Mastery of Surgery, Fischer JE, Bland KI, Callery MP (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. Copyright &copy; 2006 Lippincott Williams &amp; Wilkins.",
"        </div>",
"        <div class=\"contractual\">",
"         <br/>",
"         <a href=\"file://www.lww.com\">",
"          file://www.lww.com",
"         </a>",
"        </div>",
"       </br>",
"      </br>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_15_11514=[""].join("\n");
var outline_f11_15_11514=null;
var title_f11_15_11515="Clinical signs trachoma";
var content_f11_15_11515=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F54009&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F54009&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Simplified WHO trachoma grading system",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Grade",
"       </td>",
"       <td class=\"subtitle1\">",
"        Clinical signs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Trachomatous inflammation follicular (TF)",
"       </td>",
"       <td>",
"        Five or more follicles of &gt;0.5 mm on upper tarsal conjunctiva.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Trachomatous inflammation intense (TI)",
"       </td>",
"       <td>",
"        Inflammatory thickening obscuring more than half the normal deep tarsal vessels.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Trachomatous conjunctival scarring (TS)",
"       </td>",
"       <td>",
"        The presence of easily visible scars in the tarsal conjunctiva.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Trachomatous trichiasis (TT)",
"       </td>",
"       <td>",
"        At least one eyelash rubbing on the eyeball or evidence of recent removal of in-turned eyelashes.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Corneal opacity (CO)",
"       </td>",
"       <td>",
"        Corneal opacity blurring part of pupil margin.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_15_11515=[""].join("\n");
var outline_f11_15_11515=null;
var title_f11_15_11516="Rapid response team staffing";
var content_f11_15_11516=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F76672&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F76672&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Rapid response team staffing",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup width=\"10%\">",
"     </colgroup>",
"     <colgroup span=\"3\" width=\"30%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Physician-led",
"        <sup>",
"         [1]",
"        </sup>",
"       </td>",
"       <td class=\"subtitle1\">",
"        Non-physician-led",
"        <sup>",
"         [2]",
"        </sup>",
"       </td>",
"       <td class=\"subtitle1\">",
"        Primary team-led",
"        <sup>",
"         [3]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"7\">",
"        <strong>",
"         Team members",
"        </strong>",
"       </td>",
"       <td>",
"        Intensivist (leader)",
"       </td>",
"       <td>",
"        Physician assistant (leader)",
"       </td>",
"       <td>",
"        Patient's primary resident (leader)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Critical care nurse",
"       </td>",
"       <td>",
"        Critical care nurse",
"       </td>",
"       <td>",
"        Patient's primary nurse",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Floor nurse",
"       </td>",
"       <td>",
"        Respiratory care",
"       </td>",
"       <td>",
"        Senior nurse",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anesthesia",
"       </td>",
"       <td>",
"        Intensivist (as needed)",
"       </td>",
"       <td>",
"        Respiratory care (as needed)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Respiratory care",
"       </td>",
"       <td>",
"        Hospitalist (as needed)",
"       </td>",
"       <td>",
"        Other providers (as needed)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Physician for chest compressions",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Physician for procedures",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br/>",
"     <ol>",
"      <li>",
"       DeVita MA, Braithwaite RS, Mahidhara R, et al. Use of medical emergency team responses to reduce hospital cardiopulmonary arrests. Qual Saf Health Care 2004; 13:251.",
"      </li>",
"      <li>",
"       Dacey, et al. The effect of a rapid response team on major clinical outcome measures in a community hospital. Crit Care Med 2007; 35:2076.",
"      </li>",
"      <li>",
"       Howell MD, Ngo L, Folcarelli P, et al. Sustained effectiveness of a primary-team based rapid response system. Crit Care Med 2012; 40:2562.",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_15_11516=[""].join("\n");
var outline_f11_15_11516=null;
var title_f11_15_11517="ACE inhibitor in LV dysfunction";
var content_f11_15_11517=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F75136&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F75136&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Enalapril improves outcome in asymptomatic LV dysfunction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 397px; height: 233px; background-image: url(data:image/gif;base64,R0lGODlhjQHpAOYAAP///4CAgAAAAP8AADMzM4iIiHd3d/Dw/6qqqu7u7qCg///w8AAz//+goP9QUBAQ/1BQ/2Bg/xEREVVVVczMzP+IiNDQ/8DAwDAw//8QEP8gIGZmZgAA/yIiIkBAQJmZmURERP/g4Lu7u/9wcP/Q0ODg///MzN3d3SAg//8wMP+QkP9gYP+wsBFB//93d//AwP9AQP+AgMDA/0BA/8zW/zNc//9VVYCA/5CQ/6q7/7Cw/3Bw/4ig//8REf8zM1V3/0Rp/3eS///u7u7x/yJO/5mt//+qqo9AUO8AD7vJ/68AT2aF///d3aCQ7z8wgKBgv4BwcP+ZmWAQr68AAP+7u/8iIiAQ7/9ERAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAACNAekAAAf/gACCg4SFhoeIiYqLjI2Oj5CRkpOUlZaXmJmam5ydnp+goaKjpKWmp6ipqqusra6vsLGys7S1tre4ubq7vL2+v8DBwsPExcbHyMnKy8zNzs/Q0dLT1NXW19jZ2tvc3d7f4OHi4+Tl5ufo6err7O3u7/Dx8vP09fb3+Pn6+/z9/v8A+yUQQJAgAgAfJBAsELChQIIJBlEQQADABAEHHWq8N7CgAQAFBHwM+XGjyXsEBHwwIIAhyUIXAsiceeGkzXMsC7x8SSjmzAAeAtwc+g3BBEEpKUysCALjIplEo2470YFghw+CEi5kBFWq13ddv4pVF3as2XJlz6oFl3at221t/9/KtRZ3rt1ode/qZZZ3b7gWLSjlYPBjXV+/12gwWMwACA0AgAUTNiwU8TfFNQAkYZA58qTBhclWttwNM4AhDAJH5sGYSA4ANIAwHlKEyOLCg2vUaDwEQBDGPLz5DEq62gEFMgyZLjLZsyDWQAAQafEYNmcASxgUAe2bAQ/WQQDIfs1t+Ojizo5D4AAheSHFjH/0jpxD9uIapp8zXhyEO/gfDLz2W3jfHIaeMOqxp8ABiOQ3SGQtMJCEadNV5yAA3Mn2HQPhjTeLCCcIAuIpBh7YS4IQLLjIhZAFxhpn18U2W23ADcbYEoL8llpwsxBQkgEVmVKiibigqKI6IhAgQf8HBCgZZClDEjmLkQy2g0BBBEmAlZDnSZkLlfIksEEBCUSESpReqgJmPQkUYMCbDHGZZi1r3tNUQU+SguacodSJz0AEICCoCCR2yScqfu7j4yp7HopJov1s0MGbBsT5SFNBatUSV4Y6+gmk/6SEJyQGKFTRUhY5pUijnj4CakAiFCCooI8k9AFFIImUa0mJsNqqIq86FBJGBGzgiAgqoZrTrjD9BFSnv0oS7EZMdoAAkI5chCUBO+nak7PERUvJtCYNhECgG+TZCKqoNpVRr9CKmwi5N3WQbqnGQoIqQgpt+lS88hJCL1G3ZhminAEjMrBXIlR6MMIJD7LwVwaAAAD/BQRsCSXAjk48lgRxTqCuKL5a5rFZ5gqCLcSeJjjDkQc2+UFC+W7csgLrYYBDCd9UMEAFlpgwgA2uFCyABA/ryTFpOkTAgc48MyP0AFQPYIQjPgMtiQs/C020KxQ4fObSezX9ANTQCO2DJFkHPbQrG9Q8NpFmo53MAg28YIjahHB9RQ9vT0010FkL/jMAXPtAtQuID92DC4W/3YrIjJLtVt07K4O3AwM4oHchhg8gBNdAA27CIEL3AEDbgqTeONCKU8H14pF/zUoBElBqqdKWmY3CDhZo3gDnDjSwACJ8D0I6AIqbwIQNVYue9fPRj3449EYsv3rXkrMiKkEje2Le/14WRPDA78HfPXznxi+SvCDLNw996dL/PD8AgFtfgRBVDGCC9rVzhQhmhQBCjWJ8c7HADlCAPuERr32NCF32Dtc8EwDOB/kr3AXzxzXADSAKrxNEAF1xAgQkwISFeosCGQg8B7LveK/Q3i6GdS65jaJk/1hhA9X3QBjGQoa6qNa1wgcKHO5jhQ+IgHuQsbkXsolYCEhXCqVSggUmUQcuLJ4P7WEvH0nAhiSzXD9KgAMMXDGLENSH0ZA2RZOQ0YwRwCIPnfiPhhUgabzTyBvPOEctOmQld5xbQN7IHjkycX1+1MgGCiIBCrSRH4RMUZWO0cREbmQgE0BAQizGMnycDP8XlUyjTQKlMiJ+wojjUMAMFDRJY4Ryi0PZAAjeBIJZ7g4RCbiTvzR1y0OgEhwywAAKYOZKRIpSKt8b1SIoAIKIpEQEqLrIuxDxy27IYAYPUEAfj/mVARKwgJBQUpt0xZNB+GQm4ZJHCSDwgBu0chivdJS2jLWscgrinDJJ5ztK4DR3FrOH4rrIB7rFK2qKMRwHuAEHIhA1eBoTlocqQL6a8oF2qQpe7khoEhsajHjKiwJV2Qq/RLqqg3YDBw+YwRKB4dEDGWWaNzSpNhSAApUKo4kw4CZ6kCUAEDgyj+eQAQO1ydL1pUAFIZBSCQlxwkrZzBzXHGYwWLCCARw1qWn/YkkCmqSKai6jBNj0py+omoGrOkqrXE2FV5HBz3a+MxdkNWur0EqAMgnyGwfYwUI5CtcVlBWp8mIJlnDVSW1olKG8IKsGRkCCiAl2W4/Uxg1Smr5ckMCvi21sxAZRps6aqbDWoKlNLTsCDWR2s7RYqy90wEBD2oIEpT0tag1xLUrBiRQItEZUifra2DJ2tol4rDJFkdtpWCCst4CtBjKwgs8BNxG17cCknAraZrRVrLMIQWmZy4LnhtOUoVAtnZwWgbe6IgQqSAF3vQuJMjXJrpFdxmH5et70rpe9pBosYZ/KDI3OgL6sQK96V9Bd/EpCuOCL7zFEu9JWCLhzBTYw/yU8C9/qDoOmKGjwKh5sSQkLQ7yr2O0rWuphYoAYFdd8AA5e8dASJ+PEpbiueU2h3bLq1MWXiFvlhsFPDuxgxqV4AedWoFkce4JyXZXpK+bLigWowLQxgKiRN4E73T1CW7vsVy8NAWNPaBQCAC7FZTMAgwhPGRTJBG8hJhCiZ0bzogb1hQJSqmFTNAAGGRgBVs8sCm8OShIpQQBBm/UTfeKCphioMylCEAPT3pjPnwCnJJrSAQDU01vmBJeSUaEADqxYFS+oanMhfQoK9KuujwDp0Rw56JLqotO8NQXeoLxnUpdCugbYgASOsi7w/dSiMOXypksxZ9cuegRkboCtU/+RMkurWSKDPQovOXXoB1SWFCzAM5GXvYoOZPIDBOA1f2kx52uHYgGN1oAKpMztUgxr1Qp+RblJcdnOObfdrLAjHmNai3mLogHq1TO+udFlSfj7EzVOgbIH3o2CQ+LgnRDyALbNcG843BEQ14SToczuimPj4ozIOCbGXGaP16JNVrbwKURuiTvnudYml4Uu9wtUVrB8Eox2dMdj3gpAzcqA41bFDqydiVBP/N48r8WiTlHcVJjP3JKYtQZiAPOkz4KW06UucfM57Es83RI1zqnVc9GRwT57EyAvxNcpkW3mFnnsuJiVrASlsZqbIgIogHoj0G3adcPdF0tfWdBJEQH/DAA5EfX23N99kaQlNUkCZ9dE2gFQ+MMfggUBr/ric3ElLGkp3p+oPCQW4IAMLHzzwBATmT6rck6I/hEsyIADdo76XXT2rqJ4/d5Lb+baAwN3w7V76A0Pe9nT3ve5kC5Fdg16Teh+EaTXQO+R/4uBhERM4ha+64nfiNiP4PjUx4W5fITkwW/i+YkIAQw0gPTwByPcggWjIpAl7mn/CxToR4QK8gx+9/NCJ+FEELz2ZsFWCOJ1ABDAfYqgfuznf8hQQifEeowwEbzWaplWaF13CAeAAQqYCPv3fQ54DDRULPoiALx2aQUFAPj0LJywgR14CAzYfiEoDEIkeL1WgeSE/2lxpgkuaHkf2H8zSHZQJEWpZoKCAGz3lwk9uIDrJ4NBSIP38kWPkEyOZH+u9igYEAGL8INPmAxrtG/hlYEAsIFamH5N2IXLoG+4NwlkqAj7F2VoqAwF0CQGIIH8VgltiAgkAAMp8HZxaAyLhCd2GIZ4mIWJEAMDEAN/qAz09wHX4i/m1wh5aAgkkAJ9uIjKYACVNgjlp32MMImFgIiKiImZWFedZYN3CAmgOAiVeImkmIn6FXmZsCerKAii+IrMgGA0l4qSaIiF0Ip+iIvIQGGDSIiOUAK+SAi3KIz7MCQWkES/aInByIzz0HSI8IxlOAgxkAGjSI34YI2GgI2E8P8CKQADmueN9nAY4igIC4BsKoCO/tAXz/hpAPACGmCO8BiP8fKMRNWOGfCO+aiP15hNgmCP+BiQAhmOBOmPAImQCUkI/FiP93iODokPacGPDFmRAVEW/GiQFKmRFjkaz9gE7giSDdEVz/gEGjB7JhkPVohRFmAFSpAB09eS60CA/2IBUoAELGmT8GCB1OQEM1mTPrkOKEhoM3EESDAFUOAsTvmUUBmVUjmVVFmVVnmVWJmVWrmVXNmVXkkTAAGUKugsR3AEX+mUHhAUZ1loarmW+dSWbpmWbolOcLmWcjmXb4mXLPgPSHiFaCeGBgiYhKBahCmYgyBehRkQL7mDf9n/CYnJCY/ZmI5pmIIweaLRCRdQE5BJmSqomZK5CZk5meLjmZLHmfVgmZOAmpKgmpHAmq1pmvTgmo8gm45Am41gm7cJm9VImrgQmrvgm7oAnMHJm0VZnMZ5nMiZnMq5nMxpE7lEECAAhrMQEls2C1hWnbEQiCZYjLLAUwV4EtK0L7ZQdtgZC2wGAM+ECz4FAItUnq9AFQrxnSahEBFBn7lAnb0QaLuwSPIJC+EmTVIxEBIgCPaJC/i5C5SmC8Mii6oAAhUBoFJhnwV6CweKC6rWSP8nAPIHCxMxWP3pENKELAyqChVqCx1KAD91C8wUIiGxodYJZ0PxnD0lnbBQdkdjwKHRdgsyup27AKHN+aNAGqRCOqREWqRGeqRIWggJUBUHERIjmqTccCsdQBUCAHRQqg5NoRD58m4uURDWgp4miBGPlX1XCg0noBAdEBEvURUPExIW8z1X8qRlWgztKQhYZhAIoEsVkRQAsKPuOafIsCy5IjcKAU24wqeDcCWbCKjQIKi5UhAUsKCHKgCshicfyqiYmqmauqmc2qme+qmgGqqiOqqkWqqmeqqomqqquqqs2qqu+qqwGquyOqu0WpyBAAA7);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In the SOLVD prevention trial of 4228 patients (83 percent post-MI) with asymptomatic left ventricular dysfunction, prophylactic administration of enalapril reduced the probability of death or heart failure (p &lt;0.001).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: The SOLVD Investigators. N Engl J Med 1992; 327:685.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_15_11517=[""].join("\n");
var outline_f11_15_11517=null;
var title_f11_15_11518="Relative risk of stroke in chronic kidney disease";
var content_f11_15_11518=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F68089&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F68089&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 564px\">",
"   <div class=\"ttl\">",
"    Relative risk of stroke in chronic kidney disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 544px; height: 269px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The risk for stroke depending on different stages of CKD are shown: even patients with mild to moderate reductions in the eGFR suffer from a markedly higher stroke rate. This effect was much more impressive in patients with hemodialysis, especially if atrial fibrillation occurred. However, due to differences in patient characteristics, the concrete increase in risk differed from study to study.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br>",
"      <ol>",
"       <li>",
"        Nakayama M, Metoki H, Terawaki H, et al. Kidney dysfunction as a risk factor for first symptomatic stroke events in a general Japanese population - the Ohasama study. Nephrol Dial Transplant 2007; 22:1910-1915.",
"       </li>",
"       <li>",
"        US Renal Data System: USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD, National Institutes of Health, National Institute of Diabetes, and Digestive and Kidney Diseases, 2006.",
"       </li>",
"       <li>",
"        US Renal Data System: USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, National Institutes of Health, National Institute of Diabetes, and Digestive and Kidney Diseases, 2005.",
"       </li>",
"       <li>",
"        Vazquez E, Sanchez-Perales C, Lozano C, et al. Comparison of prognostic value of atrial fibrillation versus sinus rhythm in patients on long-term hemodialysis. Am J Cardiol 2003; 92:868-871.",
"       </li>",
"      </ol>",
"      <br>",
"       Reproduced with permission from: Reinecke H, Brand E, Mesters R, et al. Dilemmas in the management of atrial fibrillation in chronic kidney disease. J Am Soc Nephrol 2009; 20:705. Copyright &copy; 2009 American Society of Nephrology.",
"      </br>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_15_11518=[""].join("\n");
var outline_f11_15_11518=null;
var title_f11_15_11519="Contents: Hematopoietic cell transplant";
var content_f11_15_11519=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?39/57/40861\">",
"       Hematology",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Hematopoietic cell transplant",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Hematopoietic cell transplant",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Complications",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/36/1609\">",
"           Kidney disease following hematopoietic cell transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/39/28280\">",
"           Malignancy after hematopoietic cell transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/4/40009\">",
"           Pathogenesis and clinical features of hepatic sinusoidal obstruction syndrome (veno-occlusive disease) following hematopoietic cell transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/11/10425\">",
"           Prevention and treatment of acute graft-versus-host disease: Recommendations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/13/24792\">",
"           Prevention of acute graft-versus-host disease: Trials of T cell depletion",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/3/42041\">",
"           Prevention of acute graft-versus-host disease: Trials of pharmacologic therapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/10/40106\">",
"           Pulmonary complications after allogeneic hematopoietic cell transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/25/14745\">",
"           Pulmonary complications after autologous hematopoietic cell transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/59/25529\">",
"           Quality of life following hematopoietic cell transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/58/7081\">",
"           Treatment and prevention of hepatic sinusoidal obstruction syndrome following hematopoietic cell transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/32/6666\">",
"           Treatment of acute graft-versus-host disease: Clinical trials",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Donor issues",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/47/11002\">",
"           Collection and storage of umbilical cord blood for hematopoietic cell transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/50/22314\">",
"           Determining eligibility for allogeneic hematopoietic cell transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/50/19241\">",
"           Determining eligibility for autologous hematopoietic cell transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/38/26218\">",
"           Donor selection for hematopoietic cell transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/49/38682\">",
"           Sources of hematopoietic stem cells",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/14/39145\">",
"           Umbilical cord blood transplantation in adults using myeloablative and nonmyeloablative preparative regimens",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Graft-versus-host disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/22/25960\">",
"           Clinical manifestations, diagnosis, and grading of acute graft-versus-host disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/25/23962\">",
"           Clinical manifestations, diagnosis, and grading of chronic graft-versus-host disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/1/34842\">",
"           Overview of immunosuppressive agents used for prevention and treatment of graft-versus-host disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/24/18826\">",
"           Pathogenesis of graft-versus-host disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/11/10425\">",
"           Prevention and treatment of acute graft-versus-host disease: Recommendations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/13/24792\">",
"           Prevention of acute graft-versus-host disease: Trials of T cell depletion",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/3/42041\">",
"           Prevention of acute graft-versus-host disease: Trials of pharmacologic therapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/32/6666\">",
"           Treatment of acute graft-versus-host disease: Clinical trials",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/35/35385\">",
"           Treatment of chronic graft-versus-host disease",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Graft-versus-tumor",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/43/44729\">",
"           Biology of the graft-versus-tumor effect following hematopoietic cell transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/58/16298\">",
"           Immunotherapy for the prevention and treatment of relapse following hematopoietic cell transplantation",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Infection",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/32/19974\">",
"           Evaluation for infection before hematopoietic cell transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/57/25498\">",
"           Immunizations after hematopoietic cell transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/30/25066\">",
"           Overview of infections following hematopoietic cell transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/57/32666\">",
"           Prophylaxis of infections in hematopoietic cell transplant recipients",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Management",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/54/34664\">",
"           Hematopoietic support after hematopoietic cell transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/34/25130\">",
"           Preparative regimens for hematopoietic cell transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/33/37402\">",
"           Strategies for immune reconstitution following allogeneic hematopoietic cell transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/39/29306\">",
"           Supportive care after hematopoietic cell transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/44/35530\">",
"           The approach to hematopoietic cell transplantation survivorship",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Stem cells and hematopoiesis",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/34/25129\">",
"           Overview of hematopoiesis and stem cell function",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/31/15865\">",
"           Selection of an umbilical cord blood graft for hematopoietic cell transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/49/38682\">",
"           Sources of hematopoietic stem cells",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/14/39145\">",
"           Umbilical cord blood transplantation in adults using myeloablative and nonmyeloablative preparative regimens",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/45/10969\">",
"           Use of recombinant hematopoietic growth factors in stem cell and progenitor cell mobilization",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Use in specific diseases",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/47/31482\">",
"           Autologous hematopoietic cell transplantation in multiple myeloma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/25/5529\">",
"           Efficacy of hematopoietic cell transplantation in beta thalassemia major",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/11/9400\">",
"           General principles of hematopoietic cell transplantation for acute lymphoblastic leukemia in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/40/17030\">",
"           Hematopoietic cell transplantation for Diamond-Blackfan anemia and the myelodysplastic syndromes in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/18/11562\">",
"           Hematopoietic cell transplantation for idiopathic severe aplastic anemia and Fanconi anemia in children",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/50/18217\">",
"           Hematopoietic cell transplantation in aplastic anemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/61/35800\">",
"           Hematopoietic cell transplantation in chronic lymphocytic leukemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/18/33066\">",
"           Hematopoietic cell transplantation in chronic myeloid leukemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/49/21274\">",
"           Hematopoietic cell transplantation in classical Hodgkin lymphoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/39/8826\">",
"           Hematopoietic cell transplantation in myelodysplastic syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/3/30775\">",
"           Hematopoietic cell transplantation in sickle cell disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/36/43591\">",
"           Long-term management of the thalassemic patient after hematopoietic cell transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/17/25880\">",
"           Specific issues related to hematopoietic cell transplantation in beta thalassemia",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-838C22BEC7-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f11_15_11519=[""].join("\n");
var outline_f11_15_11519=null;
